Clifton David Fuller, M.D., Ph.D.

Peer-Reviewed Articles

1. Multidisciplinary Oropharyngeal Cancer Extra-Nodal Extension (OPC ENE) Assessment Working Group, Sahin O, Kamel S, Wahid KA, Dede C, Taku N, He R, Naser MA, Sharafi S, Mäkitie A, Kann BH, Kaski K, Sahlsten J, Jaskari J, Amit M, Chronowski GM, Diaz EM, Garden AS, Goepfert RP, Guenette JP, Gunn GB, Hirvonen J, Hoebers F, Hutcheson KA, Guha-Thakurta N, Johnson J, Kaya D, Khanpara SD, Nyman K, Lai SY, Lango M, Learned KO, Lee A, Lewis CM, Maniakas A, Moreno AC, Myers JN, Phan J, Pytynia KB, Rosenthal DI, Sandulache VC, Schellingerhout D, Shah SJ, Sikora AG, Mohamed ASR, Chen MM, Fuller CD. Multi-Specialty Expert Physician Identification of Extranodal Extension in Computed Tomography Scans of Oropharyngeal Cancer Patients: Prospective Blinded Human Inter-Observer Performance Evaluation. medRxiv, 2024. e-Pub 2024. PMID: 36865096.
2. Hsu EJ, Lin TA, Dabush DR, McCaw Z, Koong A, Lin C, Abi Jaoude J, Patel R, Kouzy R, El Alam MB, Noticewala S, Yang Y, Sherry AD, Fuller CD, Thomas CR, Tang C, Msaouel P, Das P, Huang B, Tian L, Sun R, Lee JJ, Meirson T, Ludmir EB. Association of differential censoring with survival and suboptimal control arms among oncology clinical trials. J Natl Cancer Inst 116(6):990-994, 2024. e-Pub 2024. PMID: 38331394.
3. Anderson BJ, Moreno AC, Qing Y, Lee JJ, Johnson FM, Lango MN, Barbon CEA, Tripuraneni L, Sahli A, Piper V, Gross N, Fuller CD, Lai SY, Myers JN, Hutcheson KA. Revisiting Feeding Tube Utilization in Oropharynx Cancer: 6-Year Prospective Registry Analysis. Otolaryngol Head Neck Surg 170(5):1319-1330, 2024. e-Pub 2024. PMID: 38353360.
4. Salama V, Humbert-Vidan L, Godinich B, Wahid KA, ElHabashy DM, Naser MA, He R, Mohamed ASR, Sahli AJ, Hutcheson KA, Gunn GB, Rosenthal DI, Fuller CD, Moreno AC. Comparison of Machine Leaning Models for Prediction of Acute Pain Severity and On-Treatment Opioid Utilization in Oral Cavity and Oropharyngeal Cancer Patients Receiving Radiation Therapy: Exploratory Analysis from a Large-Scale Retrospective Cohort. medRxiv, 2024. e-Pub 2024. PMID: 38370746.
5. McDonald BA, Cardenas CE, O'Connell N, Ahmed S, Naser MA, Wahid KA, Xu J, Thill D, Zuhour RJ, Mesko S, Augustyn A, Buszek SM, Grant S, Chapman BV, Bagley AF, He R, Mohamed ASR, Christodouleas J, Brock KK, Fuller CD. Investigation of autosegmentation techniques on T2-weighted MRI for off-line dose reconstruction in MR-linac workflow for head and neck cancers. Med Phys 51(1):278-291, 2024. e-Pub 2023. PMID: 37475466.
6. McDonald BA, Dal Bello R, Fuller CD, Balermpas P. The Use of MR-Guided Radiation Therapy for Head and Neck Cancer and Recommended Reporting Guidance. Semin Radiat Oncol 34(1):69-83, 2024. PMID: 38105096.
7. Wahid KA, Sahlsten J, Jaskari J, Dohopolski MJ, Kaski K, He R, Glerean E, Kann BH, Mäkitie A, Fuller CD, Naser MA, Fuentes D. Harnessing uncertainty in radiotherapy auto-segmentation quality assurance. Phys Imaging Radiat Oncol 29:100526, 2024. e-Pub 2023. PMID: 38179210.
8. Hughes N, Salzillo TC, Vedam S, Lim TY, Wang X, Wang H, Mohammedsaid M, Fuller CD, Wang J, Yang J. A look-up-table development to facilitate CT simulation of MR-Linac treatment. Phys Imaging Radiat Oncol 29:100524, 2024. e-Pub 2023. PMID: 38192414.
9. Maroongroge S, Mohamed AS, Nguyen C, Guma De la Vega J, Frank SJ, Garden AS, Gunn BG, Lee A, Mayo L, Moreno A, Morrison WH, Phan J, Spiotto MT, Court LE, Fuller CD, Rosenthal DI, Netherton TJ. Clinical acceptability of automatically generated lymph node levels and structures of deglutition and mastication for head and neck radiation therapy. Phys Imaging Radiat Oncol 29:100540, 2024. e-Pub 2024. PMID: 38356692.
10. Salama V, Godinich B, Geng Y, Humbert-Vidan L, Maule L, Wahid KA, Naser MA, He R, Mohamed ASR, Fuller CD, Moreno AC. Artificial Intelligence and Machine Learning in Cancer Related Pain: A Systematic Review. medRxiv, 2023. e-Pub 2023. PMID: 38105979.
11. Mayo CS, Feng MU, Brock KK, Kudner R, Balter P, Buchsbaum JC, Caissie A, Covington E, Daugherty EC, Dekker AL, Fuller CD, Hallstrom AL, Hong DS, Hong JC, Kamran SC, Katsoulakis E, Kildea J, Krauze AV, Kruse JJ, McNutt T, Mierzwa M, Moreno A, Palta JR, Popple R, Purdie TG, Richardson S, Sharp GC, Satomi S, Tarbox LR, Venkatesan AM, Witztum A, Woods KE, Yao Y, Farahani K, Aneja S, Gabriel PE, Hadjiiski L, Ruan D, Siewerdsen JH, Bratt S, Casagni M, Chen S, Christodouleas JC, DiDonato A, Hayman J, Kapoor R, Kravitz S, Sebastian S, Von Siebenthal M, Bosch W, Hurkmans C, Yom SS, Xiao Y. Operational Ontology for Oncology (O3): A Professional Society-Based, Multistakeholder, Consensus-Driven Informatics Standard Supporting Clinical and Research Use of Real-World Data From Patients Treated for Cancer. Int J Radiat Oncol Biol Phys 117(3):533-550, 2023. e-Pub 2023. PMID: 37244628.
12. Joint Head and Neck Radiotherapy-MRI Development Cooperative, Salzillo TC, Dresner MA, Way A, Wahid KA, McDonald BA, Mulder S, Naser MA, He R, Ding Y, Yoder A, Ahmed S, Corrigan KL, Manzar GS, Andring L, Pinnix C, Stafford RJ, Mohamed ASR, Christodouleas J, Wang J, Fuller CD. Development and implementation of optimized endogenous contrast sequences for delineation in adaptive radiotherapy on a 1.5T MR-linear-accelerator: a prospective R-IDEAL stage 0-2a quantitative/qualitative evaluation of in vivo site-specific quality-assurance using a 3D T2 fat-suppressed platform for head and neck cancer. J Med Imaging (Bellingham) 10(6):065501, 2023. e-Pub 2023. PMID: 37937259.
13. Wahid KA, Cardenas CE, Marquez B, Netherton TJ, Kann BH, Court LE, He R, Naser MA, Moreno AC, Fuller CD, Fuentes D. Evolving Horizons in Radiotherapy Auto-Contouring: Distilling Insights, Embracing Data-Centric Frameworks, and Moving Beyond Geometric Quantification. ArXiv, 2023. e-Pub 2023. PMID: 37904737.
14. Canahuate G, Wentzel A, Mohamed ASR, van Dijk LV, Vock DM, Elgohari B, Elhalawani H, Fuller CD, Marai GE. Spatially-aware clustering improves AJCC-8 risk stratification performance in oropharyngeal carcinomas. Oral Oncol 144:106460, 2023. e-Pub 2023. PMID: 37390759.
15. Zhao Y, Chen X, McDonald B, Yu C, Mohamed ASR, Fuller CD, Court LE, Pan T, Wang H, Wang X, Phan J, Yang J. A transformer-based hierarchical registration framework for multimodality deformable image registration. Comput Med Imaging Graph 108:102286, 2023. e-Pub 2023. PMID: 37625307.
16. Wahid KA, Sahin O, Kundu S, Lin D, Alanis A, Tehami S, Kamel S, Duke S, Sherer MV, Rasmussen M, Korreman S, Fuentes D, Cislo M, Nelms BE, Christodouleas JP, Murphy JD, Mohamed ASR, He R, Naser MA, Gillespie EF, Fuller CD. Determining The Role Of Radiation Oncologist Demographic Factors On Segmentation Quality: Insights From A Crowd-Sourced Challenge Using Bayesian Estimation. medRxiv, 2023. e-Pub 2023. PMID: 37693394.
17. Gronberg MP, Jhingran A, Netherton TJ, Gay SS, Cardenas CE, Chung C, Fuentes D, Fuller CD, Howell RM, Khan M, Lim TY, Marquez B, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep learning-based dose prediction to improve the plan quality of volumetric modulated arc therapy for gynecologic cancers. Med Phys. e-Pub 2023. PMID: 37706560.
18. Watson EE, Hueniken K, Lee J, Huang SH, Maghrabi A AE, Xu W, Moreno AC, Tsai CJ, Hahn E, McPartlin AJ, Yao CM, Goldstein DP, De Almeida JR, Waldon JN, Fuller CD, Hope AJ, Ruggiero SL, Glogauer M, Hosni AA. Development and Standardization of a Classification System for Osteoradionecrosis: Implementation of a Risk-Based Model. medRxiv, 2023. e-Pub 2023. PMID: 37745576.
19. MD Anderson Head and Neck Radiation Oncology and Cardiovascular Working Group, Koutroumpakis E, Mohamed ASR, Chaftari P, Rosenthal DI, Gujral D, Nutting C, Kim P, Bassett R, Fuller CD, Mouhayar E. Longitudinal Changes in the Carotid Arteries of Head and Neck Cancer Patients Following Radiation Therapy: Results from a Prospective Serial Imaging Biomarker Characterization Study. medRxiv, 2023. e-Pub 2023. PMID: 37790305.
20. Sherry AD, Msaouel P, McCaw ZR, Abi Jaoude J, Hsu EJ, Kouzy R, Patel R, Yang Y, Lin TA, Taniguchi CM, Rödel C, Fokas E, Tang C, Fuller CD, Minsky B, Meirson T, Sun R, Ludmir EB. Prevalence and implications of significance testing for baseline covariate imbalance in randomised cancer clinical trials: The Table 1 Fallacy. Eur J Cancer 194:113357. e-Pub 2023. PMID: 37827064.
21. Contrera KJ, Phan J, Waguespack SG, Aldehaim M, Wang X, Lim TY, Roberts DB, Fuller CD, Spiotto MT, Raza SM, DeMonte F, Hanna EY, Su SY. Prevalence of pituitary hormone dysfunction following radiotherapy for sinonasal and nasopharyngeal malignancies. Head Neck. e-Pub 2023. PMID: 37534890.
22. Rooney MK, Sharifi B, Ludmir EB, Fuller CD, Warner JL. Factors Associated With Altmetric Attention Scores for Randomized Phase III Cancer Clinical Trials. JCO Clin Cancer Inform 7:e2300082, 2023. PMID: 37552823.
23. Ye Z, Saraf A, Ravipati Y, Hoebers F, Catalano PJ, Zha Y, Zapaishchykova A, Likitlersuang J, Guthier C, Tishler RB, Schoenfeld JD, Margalit DN, Haddad RI, Mak RH, Naser M, Wahid KA, Sahlsten J, Jaskari J, Kaski K, Mäkitie AA, Fuller CD, Aerts HJWL, Kann BH. Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer. JAMA Netw Open 6(8):e2328280, 2023. e-Pub 2023. PMID: 37561460.
24. El-Habashy DM, Wahid KA, He R, McDonald BA, Mulder SJ, Ding YA, Salzillo TC, Lai S, Christodouleas J, Dresner A, Wang J, Naser MA, Fuller CD, Mohamed ASR. Weekly Intra-Treatment Diffusion Weighted Imaging Dataset for Head and Neck Cancer Patients Undergoing MR-linac Treatment. medRxiv, 2023. e-Pub 2023. PMID: 37645931.
25. Cass S, Cope B, Bishop AJ, Chiang YJ, Ashleigh Guadagnolo B, Farooqi A, Morrison W, Witt RG, Seervai RNH, Garden AS, Fuller CD, Goepfert RP, Ross M, Gershenwald JE, Wong M, Aung PP, Keung EZ, Mitra D. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes. Radiother Oncol:109892. e-Pub 2023. PMID: 37659660.
26. Rooney MK, Andring LM, Corrigan KL, Bernard V, Williamson TD, Fuller CD, Garden AS, Gunn B, Lee A, Moreno AC, Morrison WH, Phan J, Rosenthal DI, Spiotto M, Frank SJ. Hypothyroidism following Radiotherapy for Head and Neck Cancer: A Systematic Review of the Literature and Opportunities to Improve the Therapeutic Ratio. Cancers (Basel) 15(17), 2023. e-Pub 2023. PMID: 37686597.
27. Yorke AA, Rooney MK, Rigert J, Moreno AC, Fuller CD, Ford EC. National Institutes of Health Diversity Supplement Awards: Experience of Radiation Oncology Principal Investigators and Trainees. Int J Radiat Oncol Biol Phys 116(2):375-378, 2023. PMID: 37179091.
28. Moreno A, Solanki AA, Xu T, Lin R, Palta J, Daugherty E, Hong D, Hong J, Kamran SC, Katsoulakis E, Brock K, Feng M, Fuller C, Mayo C, BDSC Prostate Cancer Consortium. Identification of Key Elements in Prostate Cancer for Ontology Building via a Multidisciplinary Consensus Agreement. Cancers (Basel) 15(12), 2023. e-Pub 2023. PMID: 37370731.
29. Florez MA, Jaoude JA, Patel RR, Kouzy R, Lin TA, De B, Beck EJ, Taniguchi CM, Minsky BD, Fuller CD, Lee JJ, Kupferman M, Raghav KP, Overman MJ, Thomas CR, Ludmir EB. Incidence of Primary End Point Changes Among Active Cancer Phase 3 Randomized Clinical Trials. JAMA Netw Open 6(5):e2313819, 2023. e-Pub 2023. PMID: 37195664.
30. Bahig H, Ehab HY, Garden AS, Ng SP, Frank SJ, Nguyen T, Gunn GB, Rosenthal DI, Fuller CD, Ferrarotto R, Bell D, Su S, Phan J. Long-term outcomes of modern multidisciplinary management of sinonasal cancers: The M. D. Anderson experience. Head Neck. e-Pub 2023. PMID: 37165701.
31. Joint Head and Neck Radiation Therapy-MRI Development Cooperative, MR-Linac Consortium Head and Neck Tumor Site Group, El-Habashy DM, Wahid KA, He R, McDonald B, Rigert J, Mulder SJ, Lim TY, Wang X, Yang J, Ding Y, Naser MA, Ng SP, Bahig H, Salzillo TC, Preston KE, Abobakr M, Shehata MA, Elkhouly EA, Alagizy HA, Hegazy AH, Mohammadseid M, Terhaard C, Philippens M, Rosenthal DI, Wang J, Lai SY, Dresner A, Christodouleas JC, Mohamed ASR, Fuller CD. Longitudinal diffusion and volumetric kinetics of head and neck cancer magnetic resonance on a 1.5T MR-Linear accelerator hybrid system: A prospective R-IDEAL Stage 2a imaging biomarker characterization/ pre-qualification study. medRxiv, 2023. e-Pub 2023. PMID: 37205359.
32. McDonald BA, Salzillo T, Mulder S, Ahmed S, Dresner A, Preston K, He R, Christodouleas J, Mohamed ASR, Philippens M, van Houdt P, Thorwarth D, Wang J, Shukla Dave A, Boss M, Fuller CD. Prospective evaluation of in vivo and phantom repeatability and reproducibility of diffusion-weighted MRI sequences on 1.5 T MRI-linear accelerator (MR-Linac) and MR simulator devices for head and neck cancers. Radiother Oncol 185:109717. e-Pub 2023. PMID: 37211282.
33. McKearnan SB, Vock DM, Marai GE, Canahuate G, Fuller CD, Wolfson J. Feature selection for support vector regression using a genetic algorithm. Biostatistics 24(2):295-308, 2023. PMID: 34494086.
34. Ye Z, Saraf A, Ravipati Y, Hoebers F, Zha Y, Zapaishchykova A, Likitlersuang J, Tishler RB, Schoenfeld JD, Margalit DN, Haddad RI, Mak RH, Naser M, Wahid KA, Sahlsten J, Jaskari J, Kaski K, Mäkitie AA, Fuller CD, Aerts HJWL, Kann BH. Fully-automated sarcopenia assessment in head and neck cancer: development and external validation of a deep learning pipeline. medRxiv, 2023. e-Pub 2023. PMID: 36945519.
35. Koong A, Gardner UG, Burton J, Stewart C, Thompson P, Fuller CD, Ludmir EB, Rooney MK. Factors Associated With Open Access Publishing Costs in Oncology Journals: Cross-sectional Observational Study. JMIR Form Res 7:e44633, 2023. e-Pub 2023. PMID: 36927553.
36. Wahid KA, Lin D, Sahin O, Cislo M, Nelms BE, He R, Naser MA, Duke S, Sherer MV, Christodouleas JP, Mohamed ASR, Murphy JD, Fuller CD, Gillespie EF. Large scale crowdsourced radiotherapy segmentations across a variety of cancer anatomic sites. Sci Data 10(1):161, 2023. e-Pub 2023. PMID: 36949088.
37. Joint Head and Neck Radiotherapy-MRI Development Cooperative, Mohamed ASR, Abusaif A, He R, Wahid KA, Salama V, Youssef S, McDonald BA, Naser M, Ding Y, Salzillo TC, AboBakr MA, Wang J, Lai SY, Fuller CD. Prospective validation of diffusion-weighted MRI as a biomarker of tumor response and oncologic outcomes in head and neck cancer: Results from an observational biomarker pre-qualification study. Radiother Oncol 183:109641. e-Pub 2023. PMID: 36990394.
38. Hosseinian S, Hemmati M, Dede C, Salzillo TC, van Dijk LV, Mohamed ASR, Lai SY, Schaefer AJ, Fuller CD. Cluster-Based Toxicity Estimation of Osteoradionecrosis via Unsupervised Machine Learning: Moving Beyond Single Dose-Parameter Normal Tissue Complication Probability by Using Whole Dose-Volume Histograms for Cohort Risk Stratification. medRxiv, 2023. e-Pub 2023. PMID: 37034700.
39. Lin D, Wahid KA, Nelms BE, He R, Naser MA, Duke S, Sherer MV, Christodouleas JP, Mohamed ASR, Cislo M, Murphy JD, Fuller CD, Gillespie EF. E pluribus unum: prospective acceptability benchmarking from the Contouring Collaborative for Consensus in Radiation Oncology crowdsourced initiative for multiobserver segmentation. J Med Imaging (Bellingham) 10(Suppl 1):S11903, 2023. e-Pub 2023. PMID: 36761036.
40. Sahlsten J, Jaskari J, Wahid KA, Ahmed S, Glerean E, He R, Kann BH, Mäkitie A, Fuller CD, Naser MA, Kaski K. Application of simultaneous uncertainty quantification for image segmentation with probabilistic deep learning: Performance benchmarking of oropharyngeal cancer target delineation as a use-case. medRxiv, 2023. e-Pub 2023. PMID: 36865296.
41. van Dijk LV, Mohamed AS, Ahmed S, Nipu N, Marai GE, Wahid K, Sijtsema NM, Gunn B, Garden AS, Moreno A, Hope AJ, Langendijk JA, Fuller CD. Head and neck cancer predictive risk estimator to determine control and therapeutic outcomes of radiotherapy (HNC-PREDICTOR): development, international multi-institutional validation, and web implementation of clinic-ready model-based risk stratification for head and neck cancer. Eur J Cancer 178:150-161, 2023. e-Pub 2022. PMID: 36442460.
42. Chowdhry AK, Mayo D, Pugh SL, Park J, Fuller CD, Kang J. In Regard to Fornacon-Wood et al. Int J Radiat Oncol Biol Phys 115(1):249-250, 2023. PMID: 36526385.
43. Wang JH, Salama V, McCoy L, Dede C, Ajayi T, Moreno A, Mohamed ASR, Hutcheson KA, Fuller CD, van Dijk LV, MD Anderson Head and Neck Symptom Working Group. Dysphagia and shortness-of-breath as markers for treatment failure and survival in oropharyngeal cancer after radiation. Radiother Oncol 180:109465. e-Pub 2023. PMID: 36640945.
44. Gronberg MP, Beadle BM, Garden AS, Skinner H, Gay S, Netherton T, Cao W, Cardenas CE, Chung C, Fuentes DT, Fuller CD, Howell RM, Jhingran A, Lim TY, Marquez B, Mumme R, Olanrewaju AM, Peterson CB, Vazquez I, Whitaker TJ, Wooten Z, Yang M, Court LE. Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. Pract Radiat Oncol. e-Pub 2023. PMID: 36697347.
45. Caissie A, Mierzwa M, Fuller CD, Rajaraman M, Lin A, MacDonald A, Popple R, Xiao Y, VanDijk L, Balter P, Fong H, Xu H, Kovoor M, Lee J, Rao A, Martel M, Thompson R, Merz B, Yao J, Mayo C. Head and Neck Radiation Therapy Patterns of Practice Variability Identified as a Challenge to Real-World Big Data: Results From the Learning from Analysis of Multicentre Big Data Aggregation (LAMBDA) Consortium. Adv Radiat Oncol 8(1):100925, 2023. e-Pub 2022. PMID: 36711064.
46. Sahlsten J, Wahid KA, Glerean E, Jaskari J, Naser MA, He R, Kann BH, Mäkitie A, Fuller CD, Kaski K. Segmentation stability of human head and neck cancer medical images for radiotherapy applications under de-identification conditions: Benchmarking data sharing and artificial intelligence use-cases. Front Oncol 13:1120392, 2023. e-Pub 2023. PMID: 36925936.
47. Reber B, Van Dijk L, Anderson B, Mohamed ASR, Fuller C, Lai S, Brock K. Comparison of Machine-Learning and Deep-Learning Methods for the Prediction of Osteoradionecrosis Resulting From Head and Neck Cancer Radiation Therapy. Adv Radiat Oncol 8(4):101163, 2023. e-Pub 2022. PMID: 36798732.
48. Andrearczyk V, Oreiller V, Abobakr M, Akhavanallaf A, Balermpas P, Boughdad S, Capriotti L, Castelli J, Le Rest CC, Decazes P, Correia R, El-Habashy D, Elhalawani H, Fuller CD, Jreige M, Khamis Y, La Greca A, Mohamed A, Naser M, Prior JO, Ruan S, Tanadini-Lang S, Tankyevych O, Salimi Y, Vallières M, Vera P, Visvikis D, Wahid K, Zaidi H, Hatt M, Depeursinge A. Overview of the HECKTOR Challenge at MICCAI 2022: Automatic Head and Neck Tumor Segmentation and Outcome Prediction in PET/CT. Head Neck Tumor Chall (2022) 13626:1-30, 2023. e-Pub 2023. PMID: 37195050.
49. Wentzel A, Mohamed ASR, Naser MA, van Dijk LV, Hutcheson K, Moreno AM, Fuller CD, Canahuate G, Marai GE. Multi-organ spatial stratification of 3-D dose distributions improves risk prediction of long-term self-reported severe symptoms in oropharyngeal cancer patients receiving radiotherapy: development of a pre-treatment decision support tool. Front Oncol 13:1210087, 2023. e-Pub 2023. PMID: 37614495.
50. Naser MA, Wahid KA, Ahmed S, Salama V, Dede C, Edwards BW, Lin R, McDonald B, Salzillo TC, He R, Ding Y, Abdelaal MA, Thill D, O'Connell N, Willcut V, Christodouleas JP, Lai SY, Fuller CD, Mohamed ASR. Quality assurance assessment of Intra-Acquisition Diffusion-Weighted and T2-Weighted magnetic resonance imaging registration and contour propagation for head and neck cancer radiotherapy. Med Phys. e-Pub 2022. PMID: 36519973.
51. Gidwani M, Chang K, Patel JB, Hoebel KV, Ahmed SR, Singh P, Fuller CD, Kalpathy-Cramer J. Inconsistent Partitioning and Unproductive Feature Associations Yield Idealized Radiomic Models. Radiology:220715. e-Pub 2022. PMID: 36537895.
52. Wilde DC, Kansara S, Banner L, Morlen R, Hernandez D, Huang AT, Mai W, Fuller CD, Lai S, Sandulache VC. Early detection of mandible osteoradionecrosis risk in a high comorbidity veteran population. Am J Otolaryngol 44(2):103781. e-Pub 2022. PMID: 36640532.
53. Humbert-Vidan L, Hansen CR, Fuller CD, Petit S, van der Schaaf A, van Dijk LV, Verduijn GM, Langendijk H, Muñoz-Montplet C, Heemsbergen W, Witjes M, Mohamed ASR, Khan AA, Marruecos Querol J, Oliveras Cancio I, Patel V, King AP, Johansen J, Guerrero Urbano T. Protocol Letter: A multi-institutional retrospective case-control cohort investigating PREDiction models for mandibular OsteoRadioNecrosis in head and neck cancer (PREDMORN). Radiother Oncol 176:99-100, 2022. e-Pub 2022. PMID: 36179801.
54. Contrera KJ, Zafereo ME, Yaniv D, Roberts DB, Gillenwater AM, Hanna EY, Weber RS, Myers JN, Chang EI, Garvey PB, Hanasono MM, Yu P, Hutcheson KA, Fuller CD, Tyler MA, Neskey DM. Outcomes for recurrent oral cavity squamous cell carcinoma. Oral Oncol 134:106127, 2022. e-Pub 2022. PMID: 36155359.
55. Barbon CEA, Peterson CB, Moreno AC, Lai SY, Reddy JP, Sahli A, Martino R, Johnson FM, Fuller CD, Hutcheson KA. Adhering to Eat and Exercise Status During Radiotherapy for Oropharyngeal Cancer for Prevention and Mitigation of Radiotherapy-Associated Dysphagia. JAMA Otolaryngol Head Neck Surg 148(10):956-964, 2022. e-Pub 2022. PMID: 36074459.
56. Wahid KA, Glerean E, Sahlsten J, Jaskari J, Kaski K, Naser MA, He R, Mohamed ASR, Fuller CD. Artificial Intelligence for Radiation Oncology Applications Using Public Datasets. Semin Radiat Oncol 32(4):400-414, 2022. PMID: 36202442.
57. Hemmati M, Barbon C, Mohamed ASR, van Dijk LV, Moreno AC, Gross ND, Goepfert RP, Lai SY, Hutcheson KA, Schaefer AJ, Fuller CD, MD Anderson Head and Neck Cancer Symptom Working Group. Optimized decision support for selection of transoral robotic surgery or (chemo)radiation therapy based on posttreatment swallowing toxicity. Cancer Med. e-Pub 2022. PMID: 36229990.
58. Das P, De D, Maiti R, Kamal M, Hutcheson KA, Fuller CD, Chakraborty B, Peterson CB. Estimating the optimal linear combination of predictors using spherically constrained optimization. BMC Bioinformatics 23(Suppl 3):436, 2022. e-Pub 2022. PMID: 36261805.
59. Lavigne D, Ng SP, O'Sullivan B, Nguyen-Tan PF, Filion E, Létourneau-Guillon L, Fuller CD, Bahig H. Magnetic Resonance-Guided Radiation Therapy for Head and Neck Cancers. Curr Oncol 29(11):8302-8315, 2022. e-Pub 2022. PMID: 36354715.
60. Barbon CEA, Yao CMK, Peterson CB, Moreno AC, Goepfert RP, Johnson FM, Chronowski GM, Fuller CD, Gross ND, Hutcheson KA. Swallowing After Primary TORS and Unilateral or Bilateral Radiation for Low- to Intermediate-Risk Tonsil Cancer. Otolaryngol Head Neck Surg 167(3):1945998211059967, 2022. e-Pub 2021. PMID: 34784256.
61. Kim H, Lee P, Tree AC, Chuong MD, Raldow AC, Kishan AU, Fuller CD, Rosenberg SA, Hall WA, Chie EK, Portelance L. Adaptive Radiation Therapy Physician Guidelines: Recommendations From an Expert Users' Panel. Pract Radiat Oncol 12(5):e355-e362, 2022. e-Pub 2022. PMID: 35644469.
62. Taku N, Wahid KA, van Dijk LV, Sahlsten J, Jaskari J, Kaski K, Fuller CD, Naser MA. Auto-detection and segmentation of involved lymph nodes in HPV-associated oropharyngeal cancer using a convolutional deep learning neural network. Clin Transl Radiat Oncol 36:47-55, 2022. e-Pub 2022. PMID: 35782963.
63. Taku N, Chronowski G, Brandon Gunn G, Morrison WH, Gross ND, Moreno AC, Ferrarotto R, Frank SJ, Fuller CD, Goepfert RP, Phan J, Lai SY, Reddy JP, Rosenthal DI, Garden AS. Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 113(5):1054-1062, 2022. e-Pub 2022. PMID: 35504500.
64. Thawani R, Kim MS, Arastu A, Feng Z, West MT, Taflin NF, Thein KZ, Li R, Geltzeiler M, Lee N, Fuller CD, Grandis JR, Floudas CS, Heinrich MC, Hanna E, Chandra RA. The contemporary management of cancers of the sinonasal tract in adults. CA Cancer J Clin. e-Pub 2022. PMID: 35916666.
65. Wahid KA, Olson B, Jain R, Grossberg AJ, El-Habashy D, Dede C, Salama V, Abobakr M, Mohamed ASR, He R, Jaskari J, Sahlsten J, Kaski K, Fuller CD, Naser MA. Muscle and adipose tissue segmentations at the third cervical vertebral level in patients with head and neck cancer. Sci Data 9(1):470, 2022. e-Pub 2022. PMID: 35918336.
66. Ng SP, Cardenas CE, Bahig H, Elgohari B, Wang J, Johnson JM, Moreno AC, Shah SJ, Garden AS, Phan J, Gunn GB, Frank SJ, Ding Y, Na L, Yuan Y, Urbauer D, Mohamed ASR, Rosenthal DI, Morrison WH, MacManus MP, Fuller CD. Changes in Apparent Diffusion Coefficient (ADC) in Serial Weekly MRI during Radiotherapy in Patients with Head and Neck Cancer: Results from the PREDICT-HN Study. Curr Oncol 29(9):6303-6313, 2022. e-Pub 2022. PMID: 36135064.
67. Lakomy DS, Yang J, Vedam S, Wang J, Lee B, Sobremonte A, Castillo P, Hughes N, Mohammedsaid M, Jhingran A, Klopp AH, Choi S, Fuller CD, Lin LL. Clinical implementation and initial experience with a 1.5 Tesla MR-linac for MR-guided radiotherapy for gynecologic cancer: An R-IDEAL stage 1/2a first in humans/feasibility study of new technology implementation. Pract Radiat Oncol 12(4):e296-e305, 2022. e-Pub 2022. PMID: 35278717.
68. Cardenas CE, Blinde SE, Mohamed ASR, Ng SP, Raaijmakers C, Philippens M, Kotte A, Al-Mamgani AA, Karam I, Thomson DJ, Robbins J, Newbold K, Fuller CD, Terhaard C. Comprehensive Quantitative Evaluation of Variability in MR-guided Delineation of Oropharyngeal Gross Tumor Volumes and High-risk Clinical Target Volumes: An R-IDEAL Stage 0 Prospective Study. Int J Radiat Oncol Biol Phys 113(2):426-436, 2022. e-Pub 2022. PMID: 35124134.
69. Contrera KJ, Chinn SB, Weber RS, Roberts D, Myers JN, Lai SY, Lewis CM, Hessel AC, Gillenwater AM, Mulcahy CF, Yu P, Hanasono MM, Fuller CD, Chambers MS, Zafereo ME. Outcomes after definitive surgery for mandibular osteoradionecrosis. Head Neck 44(6):1313-1323, 2022. e-Pub 2022. PMID: 35238096.
70. Aggarwal P, Nader ME, Gidley PW, Pratihar R, Jivani S, Garden AS, Mott FE, Goepfert RP, Ogboe CW, Charles C, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Hutcheson KA, Shete S. Association of hearing loss and tinnitus symptoms with health-related quality of life among long-term oropharyngeal cancer survivors. Cancer Med. e-Pub 2022. PMID: 35695117.
71. Glas HH, Kraeima J, Tribius S, Leusink FKJ, Rendenbach C, Heiland M, Stromberger C, Rashad A, Fuller CD, Mohamed ASR, Lai SY, Witjes MJH. Three-Dimensional Evaluation of Isodose Radiation Volumes in Cases of Severe Mandibular Osteoradionecrosis for the Prediction of Recurrence after Segmental Resection. J Pers Med 12(5), 2022. e-Pub 2022. PMID: 35629256.
72. Oreiller V, Andrearczyk V, Jreige M, Boughdad S, Elhalawani H, Castelli J, Vallières M, Zhu S, Xie J, Peng Y, Iantsen A, Hatt M, Yuan Y, Ma J, Yang X, Rao C, Pai S, Ghimire K, Feng X, Naser MA, Fuller CD, Yousefirizi F, Rahmim A, Chen H, Wang L, Prior JO, Depeursinge A. Head and neck tumor segmentation in PET/CT: The HECKTOR challenge. Med Image Anal 77:102336, 2022. e-Pub 2021. PMID: 35016077.
73. Aggarwal P, Hutcheson KA, Goepfert RP, Garden AS, Garg N, Mott FE, Fuller CD, Lai SY, Gunn GB, Chambers MS, Hanna EY, Sturgis EM, Shete S. Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors. Head Neck 44(4):952-963, 2022. e-Pub 2022. PMID: 35084077.
74. Mulder SL, Heukelom J, McDonald BA, Van Dijk L, Wahid KA, Sanders K, Salzillo TC, Hemmati M, Schaefer A, Fuller CD. MR-Guided Adaptive Radiotherapy for OAR Sparing in Head and Neck Cancers. Cancers (Basel) 14(8), 2022. e-Pub 2022. PMID: 35454816.
75. Tardini E, Zhang X, Canahuate G, Wentzel A, Mohamed ASR, Van Dijk L, Fuller CD, Marai GE. Optimal Treatment Selection in Sequential Systemic and Locoregional Therapy of Oropharyngeal Squamous Carcinomas: Deep Q-Learning With a Patient-Physician Digital Twin Dyad. J Med Internet Res 24(4):e29455, 2022. e-Pub 2022. PMID: 35442211.
76. Aggarwal P, Hutcheson KA, Yu R, Wang J, Fuller CD, Garden AS, Goepfert RP, Rigert J, Mott FE, Lu C, Lai SY, Gunn GB, Chambers MS, Li G, Wu CC, Hanna EY, Sturgis EM, Shete S. Genetic susceptibility to patient-reported xerostomia among long-term oropharyngeal cancer survivors. Sci Rep 12(1):6662, 2022. e-Pub 2022. PMID: 35459784.
77. Rooney MK, Nesbit EG, Holliday EB, Jagsi R, Fuller CD, Ludmir EB, Sachdev S. Trends in Publication Speed of Radiation Oncology Research from 2010 to 2019. Adv Radiat Oncol 7(2):100863, 2022. e-Pub 2021. PMID: 35036635.
78. Engeseth GM, Hysing LB, Yepes P, Pettersen HES, Mohan R, Fuller CD, Stokkevåg CH, Wu R, Zhang X, Frank SJ, Gunn GB. Impact of RBE variations on risk estimates of temporal lobe necrosis in patients treated with intensity-modulated proton therapy for head and neck cancer. Acta Oncol 61(2):1-8, 2022. e-Pub 2021. PMID: 34534047.
79. Stieb S, Engeseth GM, Mohamed ASR, He R, Perez-Martinez I, Rock S, Deshpande TS, Garden AS, Rosenthal DI, Frank SJ, Gunn GB, Fuller CD. The influence of radiation dose on taste impairment in a prospective observational study cohort of oropharyngeal cancer patients. Acta Oncol 61(2):146-152, 2022. e-Pub 2022. PMID: 35060430.
80. Patel RR, Parisi R, Verma V, Kouzy R, Abi Jaoude J, Lin TA, Fuller CD, VanderWalde NA, Jagsi R, Smith BD, Guadagnolo BA, Thomas CR, Ludmir EB. Association between Prior Malignancy Exclusion Criteria and Age Disparities in Cancer Clinical Trials. Cancers (Basel) 14(4), 2022. e-Pub 2022. PMID: 35205795.
81. Lim SY, Tran A, Tran ANK, Sobremonte A, Fuller CD, Simmons L, Yang J. Dose accumulation of daily adaptive plans to decide optimal plan adaptation strategy for head-and-neck patients treated with MR-Linac. Med Dosim 47(1):103-109, 2022. e-Pub 2021. PMID: 34756493.
82. Hall WA, Paulson E, Li XA, Erickson B, Schultz C, Tree A, Awan M, Low DA, McDonald BA, Salzillo T, Glide-Hurst CK, Kishan AU, Fuller CD. Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians. CA Cancer J Clin 72(1):34-56, 2022. e-Pub 2021. PMID: 34792808.
83. Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, Fuller CD, Ludmir EB. The Radiotherapy Quality Assurance Gap Among Phase III Cancer Clinical Trials. Radiother Oncol 166:51-57, 2022. e-Pub 2021. PMID: 34838891.
84. Wahid KA, Ahmed S, He R, van Dijk LV, Teuwen J, McDonald BA, Salama V, Mohamed ASR, Salzillo T, Dede C, Taku N, Lai SY, Fuller CD, Naser MA. Evaluation of deep learning-based multiparametric MRI oropharyngeal primary tumor auto-segmentation and investigation of input channel effects: Results from a prospective imaging registry. Clin Transl Radiat Oncol 32:6-14, 2022. e-Pub 2021. PMID: 34765748.
85. van Dijk LV, Frank SJ, Yuan Y, Gunn B, Moreno AC, Mohamed ASR, Preston KE, Qing Y, Spiotto MT, Morrison WH, Lee A, Phan J, Garden AS, Rosenthal DI, Langendijk JA, Fuller CD. Proton Image-guided Radiation Assignment for Therapeutic Escalation via Selection of locally advanced head and neck cancer patients [PIRATES]: A Phase I safety and feasibility trial of MRI-guided adaptive particle radiotherapy. Clin Transl Radiat Oncol 32:35-40, 2022. e-Pub 2021. PMID: 34841093.
86. Wolff JE, Van Gool SW, Kutluk T, Diez B, Kebudi R, Timmermann B, Garami M, Sterba J, Fuller GN, Bison B, Kordes UR. Final results of the Choroid Plexus Tumor study CPT-SIOP-2000. J Neurooncol. e-Pub 2022. PMID: 34997889.
87. Olson B, Edwards J, Degnin C, Santucci N, Buncke M, Hu J, Chen Y, Fuller CD, Geltzeiler M, Grossberg AJ, Clayburgh D. Establishment and Validation of Pre-Therapy Cervical Vertebrae Muscle Quantification as a Prognostic Marker of Sarcopenia in Patients With Head and Neck Cancer. Front Oncol 12:812159, 2022. e-Pub 2022. PMID: 35237517.
88. Wahid KA, Xu J, El-Habashy D, Khamis Y, Abobakr M, McDonald B, O' Connell N, Thill D, Ahmed S, Sharafi CS, Preston K, Salzillo TC, Mohamed ASR, He R, Cho N, Christodouleas J, Fuller CD, Naser MA. Deep-learning-based generation of synthetic 6-minute MRI from 2-minute MRI for use in head and neck cancer radiotherapy. Front Oncol 12:975902, 2022. e-Pub 2022. PMID: 36425548.
89. McDonald BA, Zachiu C, Christodouleas J, Naser MA, Ruschin M, Sonke JJ, Thorwarth D, Létourneau D, Tyagi N, Tadic T, Yang J, Li XA, Bernchou U, Hyer DE, Snyder JE, Bubula-Rehm E, Fuller CD, Brock KK. Dose accumulation for MR-guided adaptive radiotherapy: From practical considerations to state-of-the-art clinical implementation. Front Oncol 12:1086258, 2022. e-Pub 2023. PMID: 36776378.
90. Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Lu C, Goepfert RP, Fuller CD, Lai SY, Gunn GB, Chambers MS, Sturgis EM, Hanna EY, Shete S. Determinants of patient-reported xerostomia among long-term oropharyngeal cancer survivors. Cancer 127(23):4470-4480, 2021. e-Pub 2021. PMID: 34358341.
91. de Mol van Otterloo SR, Christodouleas JP, Blezer ELA, Akhiat H, Brown K, Choudhury A, Eggert D, Erickson BA, Daamen LA, Faivre-Finn C, Fuller CD, Goldwein J, Hafeez S, Hall E, Harrington KJ, van der Heide UA, Huddart RA, Intven MPW, Kirby AM, Lalondrelle S, McCann C, Minsky BD, Mook S, Nowee ME, Oelfke U, Orrling K, Philippens MEP, Sahgal A, Schultz CJ, Tersteeg RJHA, Tijssen RHN, Tree AC, van Triest B, Tseng CL, Hall WA, Verkooijen HM, MR-Linac Consortium. Patterns of Care, Tolerability, and Safety of the First Cohort of Patients Treated on a Novel High-Field MR-Linac Within the MOMENTUM Study: Initial Results From a Prospective Multi-Institutional Registry. Int J Radiat Oncol Biol Phys 111(4):867-875, 2021. e-Pub 2021. PMID: 34265394.
92. Zahid MU, Mohsin N, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, Enderling H. Forecasting Individual Patient Response to Radiation Therapy in Head and Neck Cancer With a Dynamic Carrying Capacity Model. Int J Radiat Oncol Biol Phys 111(3):693-704, 2021. e-Pub 2021. PMID: 34102299.
93. Engeseth GM, He R, Mirkovic D, Yepes P, Mohamed ASR, Stieb S, Fuller CD, Wu R, Zhang X, Hysing LB, Pettersen HES, Stokkevåg CH, Mohan R, Frank SJ, Gunn GB. Mixed Effect Modeling of Dose and Linear Energy Transfer Correlations With Brain Image Changes After Intensity Modulated Proton Therapy for Skull Base Head and Neck Cancer. Int J Radiat Oncol Biol Phys 111(3):684-692, 2021. e-Pub 2021. PMID: 34153379.
94. Zahid MU, Mohamed ASR, Caudell JJ, Harrison LB, Fuller CD, Moros EG, Enderling H. Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization. J Pers Med 11(11), 2021. e-Pub 2021. PMID: 34834476.
95. van Dijk LV, Abusaif AA, Rigert J, Naser MA, Hutcheson KA, Lai SY, Fuller CD, Mohamed ASR, on behalf on the MD Anderson Symptom Working Group. Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in head and neck cancer patients following radiotherapy: Large-scale observational cohort. Int J Radiat Oncol Biol Phys 111(2):549-558, 2021. e-Pub 2021. PMID: 33965514.
96. Parsai S, Qiu RLJ, Qi P, Sedor G, Fuller CD, Murray E, Majkszak D, Dorio N, Koyfman S, Woody N, Joshi N, Scott JG. In vivo assessment of the safety of standard fractionation Temporally Feathered Radiation Therapy (TFRT) for head and neck squamous cell carcinoma: An R-IDEAL Stage 1/2a first-in-humans/feasibility demonstration of new technology implementation. Radiother Oncol 163:39-45, 2021. e-Pub 2021. PMID: 34333086.
97. Salzillo TC, Taku N, Wahid KA, McDonald BA, Wang J, van Dijk LV, Rigert JM, Mohamed ASR, Wang J, Lai SY, Fuller CD. Advances in Imaging for HPV-Related Oropharyngeal Cancer: Applications to Radiation Oncology. Semin Radiat Oncol 31(4):371-388, 2021. PMID: 34455992.
98. Martino R, Fitch MI, Fuller CD, Hope A, Krisciunas G, Langmore SE, Lazarus C, Macdonald CL, McCulloch T, Mills G, Palma DA, Pytynia K, Ringash J, Sultanem K, Theurer J, Thorpe KE, Hutcheson K. The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer. BMC Cancer 21(1):1100, 2021. e-Pub 2021. PMID: 34645411.
99. Wahid KA, He R, McDonald BA, Anderson BM, Salzillo T, Mulder S, Wang J, Sharafi CS, McCoy LA, Naser MA, Ahmed S, Sanders KL, Mohamed ASR, Ding Y, Wang J, Hutcheson K, Lai SY, Fuller CD, van Dijk LV. Intensity standardization methods in magnetic resonance imaging of head and neck cancer. Phys Imaging Radiat Oncol 20:88-93, 2021. e-Pub 2021. PMID: 34849414.
100. Palasi S, Zhang N, Bankston M, Godby J, Burrows H, Lagunas J, Perkison W, Gunn B, Chambers MS, Rosenthal DI, Morrison W, Garden A, Fuller CD, Giordano S, Koay EJ. Factors associated with complex oral treatment device usage in patients with head and neck cancer. Clin Transl Radiat Oncol 30:78-83, 2021. e-Pub 2021. PMID: 34430717.
101. Korte JC, Cardenas C, Hardcastle N, Kron T, Wang J, Bahig H, Elgohari B, Ger R, Court L, Fuller CD, Ng SP. Author Correction: Radiomics feature stability of open-source software evaluated on apparent diffusion coefficient maps in head and neck cancer. Sci Rep 11(1):18908, 2021. e-Pub 2021. PMID: 34535728.
102. Wentzel A, Luciani T, van Dijk LV, Taku N, Elgohari B, Mohamed ASR, Canahuate G, Fuller CD, Vock DM, Elisabeta Marai G, Spatial-Non-spatial Multi-Dimensional Analysis of Radiotherapy Treatment/Toxicity Team SMART3. Precision association of lymphatic disease spread with radiation-associated toxicity in oropharyngeal squamous carcinomas. Radiother Oncol 161:152-158, 2021. e-Pub 2021. PMID: 34126138.
103. van Houdt PJ, Saeed H, Thorwarth D, Fuller CD, Hall WA, McDonald BA, Shukla-Dave A, Kooreman ES, Philippens MEP, van Lier ALHMW, Keesman R, Mahmood F, Coolens C, Stanescu T, Wang J, Tyagi N, Wetscherek A, van der Heide UA. Integration of quantitative imaging biomarkers in clinical trials for MR-guided radiotherapy: Conceptual guidance for multicentre studies from the MR-Linac Consortium Imaging Biomarker Working Group. Eur J Cancer 153:64-71, 2021. e-Pub 2021. PMID: 34144436.
104. Gardner UG, Thompson PS, Burton J, Stewart C, Fuller CD, Rooney MK, Ludmir EB. Article Processing Charge Waiver Policies as a Barrier to Oncology Scholarship in Low- and Lower-Middle-Income Countries. JCO Glob Oncol 7:1413-1417, 2021. PMID: 34554813.
105. Abi Jaoude J, Kouzy R, Rooney M, Thompson P, Patel R, Turner MC, Ghabach M, Fuller CD, Minsky BD, Taniguchi CM, Ludmir EB. Impact factor and citation metrics in phase III cancer trials. Oncotarget 12(18):1780-1786, 2021. e-Pub 2021. PMID: 34504650.
106. van Dijk LV, Mohamed ASR, Ferrarotto R, McCoy LA, Sharafi CS, Jones E, Steele K, Moreno AC, Lai SY, Garden AS, Myers JN, Rosenthal DI, Fuller CD, Hutcheson KA, MD Anderson Symptom Working Group. The impact of induction and/or concurrent chemoradiotherapy on acute and late patient-reported symptoms in oropharyngeal cancer: Application of a mixed-model analysis of a prospective observational cohort registry. Cancer 127(14):2453-2464, 2021. e-Pub 2021. PMID: 33788956.
107. Cao J, Zhang X, Jiang B, Chen J, Wang X, Wang L, Sahoo N, Zhu XR, Ye R, Blanchard P, Garden AS, Fuller CD, Gunn GB, Frank SJ. Intensity-modulated proton therapy for oropharyngeal cancer reduces rates of late xerostomia. Radiother Oncol 160:32-39, 2021. e-Pub 2021. PMID: 33839202.
108. Elhalawani H, Cardenas CE, Volpe S, Barua S, Stieb S, Rock CB, Lin T, Yang P, Wu H, Zaveri J, Elgohari B, Abdallah LE, Jethanandani A, Mohamed ASR, Court LE, Hutcheson KA, Brandon Gunn G, Rosenthal DI, Frank SJ, Garden AS, Rao A, Fuller CD. 18FDG positron emission tomography mining for metabolic imaging biomarkers of radiation-induced xerostomia in patients with oropharyngeal cancer. Clin Transl Radiat Oncol 29:93-101, 2021. e-Pub 2021. PMID: 34195391.
109. Wang JH, Wahid KA, van Dijk LV, Farahani K, Thompson RF, Fuller CD. Radiomic biomarkers of tumor immune biology and immunotherapy response. Clin Transl Radiat Oncol 28:97-115, 2021. e-Pub 2021. PMID: 33937530.
110. Aggarwal P, Hutcheson KA, Garden AS, Mott FE, Goepfert RP, Duvall A, Fuller CD, Lai SY, Gunn GB, Sturgis EM, Hanna EY, Shete S. Association of Risk Factors With Patient-Reported Voice and Speech Symptoms Among Long-term Survivors of Oropharyngeal Cancer. JAMA Otolaryngol Head Neck Surg. e-Pub 2021. PMID: 33956062.
111. Dahlstrom KR, Song J, Thall PF, Fuller CD, Hutcheson KA, Johnson FM, Gunn GB, Phan J, Frank SJ, Morrison WH, Ferrarotto R, Rosenthal DI, Sturgis EM, Garden AS. Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer 127(8):1228-1237, 2021. e-Pub 2020. PMID: 33306202.
112. McDonald BA, Vedam S, Yang J, Wang J, Castillo P, Lee B, Sobremonte A, Ahmed S, Ding Y, Mohamed ASR, Balter P, Hughes N, Thorwarth D, Nachbar M, Philippens MEP, Terhaard CHJ, Zips D, Böke S, Awan MJ, Christodouleas J, Fuller CD, MR-Linac Consortium Head and Neck Tumor Site Group. Initial Feasibility and Clinical Implementation of Daily MR-guided Adaptive Head and Neck Cancer Radiotherapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation. Int J Radiat Oncol Biol Phys 109(5):1606-1618, 2021. e-Pub 2020. PMID: 33340604.
113. Stieb S, Mohamed ASR, He R, Zhu LL, McDonald BA, Wahid K, van Dijk LV, Ventura J, Ahmed S, McCoy L, Deshpande TS, Grant S, Reddy JP, Phan J, Garden AS, Rosenthal DI, Frank SJ, Gunn GB, Fuller CD. Development and validation of a contouring guideline for the taste bud bearing tongue mucosa. Radiother Oncol 157:63-69, 2021. e-Pub 2020. PMID: 33217499.
114. van Dijk LV, Fuller CD. Artificial Intelligence and Radiomics in Head and Neck Cancer Care: Opportunities, Mechanics, and Challenges. Am Soc Clin Oncol Educ Book 41:1-11, 2021. PMID: 33929877.
115. Goodman CR, Sim AJ, Jeans EB, Anderson JD, Dooley S, Agarwal A, Tye K, Albert A, Gillespie EF, Tendulkar RD, Fuller CD, Kavanagh BD, Campbell SR. No Longer a Match: Trends in Radiation Oncology National Resident Matching Program (NRMP) Data from 2010-2020 and Comparison Across Specialties. Int J Radiat Oncol Biol Phys. e-Pub 2021. PMID: 33716120.
116. Grossberg AJ, Rock CD, Edwards J, Mohamed ASR, Ruzensky D, Currie A, Rosemond P, Phan J, Gunn GB, Frank SJ, Morrison WH, Garden AS, Fuller CD, Rosenthal DI. Bioelectrical impedance analysis as a quantitative measure of sarcopenia in head and neck cancer patients treated with radiotherapy. Radiother Oncol 159:21-27. e-Pub 2021. PMID: 33736997.
117. Ng SP, Bahig H, Jethanandani A, Sturgis EM, Johnson FM, Elgohari B, Gunn GB, Ferrarotto R, Phan J, Rosenthal DI, Frank SJ, Fuller CD, Garden AS. Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy. Br J Cancer 124(3):628-633, 2021. e-Pub 2020. PMID: 33051590.
118. Liu W, Qdaisat A, Ferrarotto R, Fuller CD, Guo M, Meyer LA, Narayanan S, Lopez G, Cohen L, Bruera E, Hanna EY, Yeung SJ. Hypomagnesemia and survival in patients with head and neck cancers who received primary concurrent chemoradiation. Cancer 127(4):528-534, 2021. e-Pub 2020. PMID: 33085092.
119. Pasalic D, Fuller CD, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Grossberg AJ, Jagsi R, Das P, Koong AC, Rödel C, Fokas E, Thomas CR, Minsky BD, Ludmir EB. Detecting the Dark Matter of Unpublished Clinical Cancer Studies: An Analysis of Phase 3 Randomized Controlled Trials. Mayo Clin Proc 96(2):420-426, 2021. PMID: 33549260.
120. Aggarwal P, Goepfert RP, Garden AS, Garg N, Zaveri JS, Du XL, Swartz MD, Lai SY, Fuller CD, Ferrarotto R, Sturgis EM, Piller LB, Hutcheson KA. Risk and Clinical Risk Factors Associated With Late Lower Cranial Neuropathy in Long-term Oropharyngeal Squamous Cell Carcinoma Survivors. JAMA Otolaryngol Head Neck Surg. e-Pub 2021. PMID: 33538759.
121. Wilke C, Takiar V, Wang H, Moreno AC, Tung SS, Quinlan-Davidson SR, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Reddy JP, Morrison WH, Wang C, Zhao G, Hutcheson KA, Phan J. Defining the dose-volume criteria for laryngeal sparing in locally advanced oropharyngeal cancer utilizing split-field IMRT, whole-field IMRT and VMAT. J Appl Clin Med Phys 22(1):37-44, 2021. e-Pub 2020. PMID: 33277960.
122. Ng SP, Fuller CD, Skinner HD. Correlation of Circulating Tumor Cell Measurements with 3D Quantitative Tumor Characterization to Predict Clinical Outcomes in Cancer. Methods Mol Biol 2174:135-141, 2021. PMID: 32813248.
123. Bahig H, Fuller CD, Mitra A, Yoshida-Court K, Solley T, Ping Ng S, Abu-Gheida I, Elgohari B, Delgado A, Rosenthal DI, Garden AS, Frank SJ, Reddy JP, Colbert L, Klopp A. Longitudinal characterization of the tumoral microbiome during radiotherapy in HPV-associated oropharynx cancer. Clin Transl Radiat Oncol 26:98-103, 2021. e-Pub 2020. PMID: 33367119.
124. Johnson JM, Mohamed ASR, Ding Y, Wang J, Lai SY, Fuller CD, Shah R, Butler RT, Weber RS. Ultra-small superparamagnetic iron oxide (USPIO) magnetic resonance imaging in benign mixed tumor of the parotid gland. Clin Case Rep 9(1):123-127, 2021. e-Pub 2020. PMID: 33489146.
125. Barua S, Elhalawani H, Volpe S, Al Feghali KA, Yang P, Ng SP, Elgohari B, Granberry RC, Mackin DS, Gunn GB, Hutcheson KA, Chambers MS, Court LE, Mohamed ASR, Fuller CD, Lai SY, Rao A. Computed Tomography Radiomics Kinetics as Early Imaging Correlates of Osteoradionecrosis in Oropharyngeal Cancer Patients. Front Artif Intell 4:618469, 2021. e-Pub 2021. PMID: 33898983.
126. Stieb S, Lee A, van Dijk LV, Frank S, Fuller CD, Blanchard P. NTCP Modeling of Late Effects for Head and Neck Cancer: A Systematic Review. Int J Part Ther 8(1):95-107, 2021. e-Pub 2021. PMID: 34285939.
127. Gunn GB, Garden AS, Ye R, Ausat N, Dahlstrom KR, Morrison WH, Fuller CD, Phan J, Reddy JP, Shah SJ, Mayo LL, Chun SG, Chronowski GM, Moreno AC, Myers JN, Hanna EY, Esmaeli B, Gillison ML, Ferrarotto R, Hutcheson KA, Chambers MS, Ginsberg LE, El-Naggar AK, Rosenthal DI, Zhu XR, Frank SJ. Proton Therapy for Head and Neck Cancer: A 12-Year, Single-Institution Experience. Int J Part Ther 8(1):108-118, 2021. e-Pub 2021. PMID: 34285940.
128. Bahig H, Gunn BG, Garden AS, Ye R, Hutcheson K, Rosenthal DI, Phan J, Fuller CD, Morrison WH, Reddy JP, Ng SP, Gross ND, Sturgis EM, Ferrarotto R, Gillison M, Frank SJ. Patient-Reported Outcomes after Intensity-Modulated Proton Therapy for Oropharynx Cancer. Int J Part Ther 8(1):213-222, 2021. e-Pub 2021. PMID: 34285948.
129. Sherry AD, Pasalic D, Gunn GB, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Sturgis EM, Gross ND, Gillison ML, Ferrarotto R, El-Naggar AK, Garden AS, Frank SJ. Proton Beam Therapy for Head and Neck Carcinoma of Unknown Primary: Toxicity and Quality of Life. Int J Part Ther 8(1):234-247, 2021. e-Pub 2021. PMID: 34285950.
130. Hanania AN, Zhang X, Gunn GB, Rosenthal DI, Garden AS, Fuller CD, Phan J, Reddy JP, Moreno A, Chronowski G, Shah S, Ausat N, Hanna E, Ferrarotto R, Frank SJ. Proton Therapy for Major Salivary Gland Cancer: Clinical Outcomes. Int J Part Ther 8(1):261-272, 2021. e-Pub 2021. PMID: 34285952.
131. Smith GL, Fu S, Ning MS, Nguyen DK, Busse PM, Foote RL, Garden AS, Gunn GB, Fuller CD, Morrison WH, Chronowski GM, Shah SJ, Mayo LL, Phan J, Reddy JP, Snider JW, Patel SH, Katz SR, Lin A, Mohammed N, Dagan R, Lee NY, Rosenthal DI, Frank SJ. Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer. Int J Part Ther 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
132. Dionisi F, Widesott L, Van Vulpen M, Fuller CD, Frondizi R, Meneguzzo M, Blanchard P, Amichetti M, Sanguineti G. Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors. Int J Part Ther 8(1):328-338, 2021. e-Pub 2021. PMID: 34285959.
133. Thaker NG, Boyce-Fappiano D, Ning MS, Pasalic D, Guzman A, Smith G, Holliday EB, Incalcaterra J, Garden AS, Shaitelman SF, Gunn GB, Fuller CD, Blanchard P, Feeley TW, Kaplan RS, Frank SJ. Activity-Based Costing of Intensity-Modulated Proton versus Photon Therapy for Oropharyngeal Cancer. Int J Part Ther 8(1):374-382, 2021. e-Pub 2021. PMID: 34285963.
134. Kerkmeijer LGW, Valentini V, Fuller CDD, Slotman BJ. Editorial: Online Adaptive MR-Guided Radiotherapy. Front Oncol 11:748685, 2021. e-Pub 2021. PMID: 34527596.
135. Peterson SK, Basen-Engquist K, Demark-Wahnefried W, Prokhorov AV, Shinn EH, Martch SL, Beadle BM, Garden AS, Farcas E, Brandon Gunn G, Fuller CD, Morrison WH, Rosenthal DI, Phan J, Eng C, Cinciripini PM, Karam-Hage MA, Camero Garcia M, Patrick K. Feasibility of Mobile and Sensor Technology for Remote Monitoring in Cancer Care and Prevention. AMIA Annu Symp Proc 2021:979-988, 2021. e-Pub 2022. PMID: 35308916.
136. Abi Jaoude J, Kouzy R, Minsky BD, Fuller CD, Yuan Y, Do KA, Taniguchi CM, Ludmir EB. Sponsor-involved statistical analyses in Phase III cancer clinical trials. Int J Cancer 147(12):3579-3581, 2020. e-Pub 2020. PMID: 32621758.
137. Joint Head and Neck Radiation Therapy-MRI Development Cooperative, Mohamed ASR, He R, Ding Y, Wang J, Fahim J, Elgohari B, Elhalawani H, Kim AD, Ahmed H, Garcia JA, Johnson JM, Stafford RJ, Bankson JA, Chambers MS, Sandulache VC, Fuller CD, Lai SY. Quantitative Dynamic Contrast-Enhanced MRI Identifies Radiation-Induced Vascular Damage in Patients With Advanced Osteoradionecrosis: Results of a Prospective Study. Int J Radiat Oncol Biol Phys 108(5):1319-1328, 2020. e-Pub 2020. PMID: 32712257.
138. Ng SP, Wang H, Pollard C, Nguyen T, Bahig H, Fuller CD, Gunn GB, Garden AS, Reddy JP, Morrison WH, Shah S, Rosenthal DI, Frank SJ, Guha-Thakurta N, Ferrarotto R, Hanna EY, Su SY, Phan J. Patient Outcomes after Reirradiation of Small Skull Base Tumors using Stereotactic Body Radiotherapy, Intensity Modulated Radiotherapy, or Proton Therapy. J Neurol Surg B Skull Base 81(6):638-644, 2020. e-Pub 2019. PMID: 33381367.
139. Kiser KJ, Ahmed S, Stieb S, Mohamed ASR, Elhalawani H, Park PYS, Doyle NS, Wang BJ, Barman A, Li Z, Zheng WJ, Fuller CD, Giancardo L. PleThora: Pleural effusion and thoracic cavity segmentations in diseased lungs for benchmarking chest CT processing pipelines. Med Phys 47(11):5941-5952, 2020. e-Pub 2020. PMID: 32749075.
140. Kouzy R, Abi Jaoude J, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Fuller CD, Minsky BD, Rödel C, Taniguchi CM, Ludmir EB. Professional Medical Writer Assistance in Oncology Clinical Trials. Oncologist 25(11):e1812-e1815, 2020. e-Pub 2020. PMID: 32885898.
141. Moreno AC, Gunther JR, Milgrom S, Fuller CD, Williamson T, Liu A, Wu R, Zhu XR, Dabaja BS, Pinnix CC. Effect of Deep Inspiration Breath Hold on Normal Tissue Sparing With Intensity Modulated Radiation Therapy Versus Proton Therapy for Mediastinal Lymphoma. Adv Radiat Oncol 5(6):1255-1266, 2020. e-Pub 2020. PMID: 33305086.
142. Al Feghali KA, Youssef BY, Mohamed ASR, Hilal L, Smith BD, Abu-Gheida I, Farha G, Gunn GB, Phan J, Lewin J, Thekdi A, Morrison WH, Garden AS, Fuller CD, Rosenthal DI. Outcomes after radiation therapy for T2N0/stage II glottic squamous cell carcinoma. Head Neck 42(10):2791-2800, 2020. e-Pub 2020. PMID: 32484591.
143. Pasalic D, Tang C, Jagsi R, Fuller CD, Koong AC, Ludmir EB. Association of Industry Sponsorship With Cancer Clinical Trial Accrual. JAMA Oncol 6(10):1625-1627, 2020. e-Pub 2020. PMID: 32815984.
144. Engeseth GM, Stieb S, Mohamed ASR, He R, Stokkevåg CH, Brydøy M, Fuller CD, Garden AS, Rosenthal DI, Phan J, Morrison WH, Reddy JP, Wu R, Zhang X, Frank SJ, Brandon Gunn G. Outcomes and patterns of radiation associated brain image changes after proton therapy for head and neck skull base cancers. Radiother Oncol 151:119-125, 2020. e-Pub 2020. PMID: 32679304.
145. Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB. Performance Status Restriction in Phase III Cancer Clinical Trials. J Natl Compr Canc Netw 18(10):1322-1326, 2020. e-Pub 2020. PMID: 33022640.
146. Stieb S, Perez-Martinez I, Mohamed ASR, Rock S, Bajaj N, Deshpande TS, Zaid M, Garden AS, Goepfert RP, Cardoso R, Ferrarotto R, Reddy JP, Phan J, Morrison WH, Rosenthal DI, Koay EJ, Frank SJ, Fuller CD, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group. The impact of tongue-deviating and tongue-depressing oral stents on long-term radiation-associated symptoms in oropharyngeal cancer survivors. Clin Transl Radiat Oncol 24:71-78, 2020. e-Pub 2020. PMID: 32642562.
147. Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR, Minsky BD, Ludmir EB. Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials. Eur J Cancer 136:176-185, 2020. e-Pub 2020. PMID: 32702645.
148. Mesko S, Wang H, Tung S, Wang C, Pasalic D, Ning MS, Pezzi TA, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Su SY, Hanna E, Phan J. SABR for Skull Base Malignancies: A Systematic Analysis of Set-Up and Positioning Accuracy. Pract Radiat Oncol 10(5):363-371, 2020. e-Pub 2020. PMID: 32240823.
149. Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials. Cancers (Basel) 12(9), 2020. e-Pub 2020. PMID: 32947844.
150. Elhalawani H, Mohamed ASR, Elgohari B, Lin TA, Sikora AG, Lai SY, Abusaif A, Phan J, Morrison WH, Gunn GB, Rosenthal DI, Garden AS, Fuller CD, Sandulache VC. Tobacco exposure as a major modifier of oncologic outcomes in human papillomavirus (HPV) associated oropharyngeal squamous cell carcinoma. BMC Cancer 20(1):912, 2020. e-Pub 2020. PMID: 32967643.
151. McCulloch MM, Cazoulat G, Ford AC, Elgohari B, Bahig H, Kim AD, Elhalawani H, He R, Wang J, Ding Y, Mohamed AS, Polan DF, King JB, Peterson CB, Ohrt AN, Fuller CD, Lai SY, Brock KK. Biomechanical modeling of radiation dose-induced volumetric changes of the parotid glands for deformable image registration. Phys Med Biol 65(16):165017, 2020. e-Pub 2020. PMID: 32320955.
152. Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, Liao Z, Erasmus JJ, Nguyen QN. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 42(8):1939-1953, 2020. e-Pub 2020. PMID: 32129548.
153. Garden AS, Kamal M, Mohamed ASR, Frank SJ, Lewin JS, Lai SY, Morrison WH, Phan J, Ferrarotto R, Rosenthal DI, Hutcheson KA, Fuller CD, Gunn GB. Neurologic sequelae following radiation with and without chemotherapy for oropharyngeal cancer: Patient reported outcomes study. Head Neck 42(8):2137-2144, 2020. e-Pub 2020. PMID: 32212359.
154. Jain AK, Aneja S, Fuller CD, Dicker AP, Chung C, Kim E, Kirby JS, Quon H, Lam CJK, Louv WC, Ahern C, Xiao Y, McNutt TR, Housri N, Ennis RD, Kang J, Tang Y, Higley H, Berny-Lang MA, Camphausen KA. Provider Engagement in Radiation Oncology Data Science: Workshop Report. JCO Clin Cancer Inform 4:700-710, 2020. PMID: 32755458.
155. Zaid M, Koay EJ, Bajaj N, Mathew R, Xiao L, Agrawal A, Fernandes P, Burrows H, Roach MA, Wilke CT, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS. A prospective parallel design study testing non-inferiority of customized oral stents made using 3D printing or manually fabricated methods. Oral Oncol 106:104665, 2020. e-Pub 2020. PMID: 32298994.
156. Grant SR, Hutcheson KA, Ye R, Garden AS, Morrison WH, Rosenthal DI, Brandon Gunn G, Fuller CD, Phan J, Reddy JP, Moreno AC, Lewin JS, Sturgis EM, Ferrarotto R, Frank SJ. Prospective longitudinal patient-reported outcomes of swallowing following intensity modulated proton therapy for oropharyngeal cancer. Radiother Oncol 148:133-139, 2020. e-Pub 2020. PMID: 32361662.
157. Parsai S, Qiu RLJ, Qi P, Alfonso JCL, Donaghue J, Murray E, Majkszak D, Dorio N, Fuller CD, Brock K, Koyfman S, Woody N, Joshi N, Scott JG. Technical Note: A step-by-step guide to Temporally Feathered Radiation Therapy planning for head and neck cancer. J Appl Clin Med Phys 21(7):209-215, 2020. e-Pub 2020. PMID: 32383296.
158. Pasalic D, Ludmir EB, Allen PK, Thaker NG, Chapman BV, Hanna EY, Su SY, Ferrarotto R, Glisson BS, Reddy JP, Brandon Gunn G, Fuller CD, Phan J, Rosenthal DI, Morrison WH, Garden AS, Frank SJ. Patient-reported outcomes, physician-reported toxicities, and treatment outcomes in a modern cohort of patients with sinonasal cancer treated using proton beam therapy. Radiother Oncol 148:258-266, 2020. e-Pub 2020. PMID: 32417351.
159. Wentzel A, Hanula P, van Dijk LV, Elgohari B, Mohamed ASR, Cardenas CE, Fuller CD, Vock DM, Canahuate G, Marai GE. Precision toxicity correlates of tumor spatial proximity to organs at risk in cancer patients receiving intensity-modulated radiotherapy. Radiother Oncol 148:245-251, 2020. e-Pub 2020. PMID: 32422303.
160. Grant SR, Noticewala SS, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Gunn GB, Fuller CD, Thomas CR, Portelance L, Ludmir EB. Non-English language validation of patient-reported outcome measures in cancer clinical trials. Support Care Cancer 28(6):2503-2505, 2020. e-Pub 2020. PMID: 32189098.
161. Corrigan KL, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Piotrowski M, Fuller CD, Stauder MC, Shaitelman SF, Perkins GH, Woodward WA, Giordano SH, Smith BD, Ludmir EB. Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials. Oncologist 25(6):e990-e992, 2020. e-Pub 2020. PMID: 32272505.
162. Cardenas CE, Mohamed ASR, Yang J, Gooding M, Veeraraghavan H, Kalpathy-Cramer J, Ng SP, Ding Y, Wang J, Lai SY, Fuller CD, Sharp G. Head and neck cancer patient images for determining auto-segmentation accuracy in T2-weighted magnetic resonance imaging through expert manual segmentations. Med Phys 47(5):2317-2322, 2020. PMID: 32418343.
163. Slagowski JM, Ding Y, Aima M, Wen Z, Fuller CD, Chung C, Debnam JM, Hwang KP, Kadbi M, Szklaruk J, Wang J. A modular phantom and software to characterize 3D geometric distortion in MRI. Phys Med Biol. e-Pub 2020. PMID: 32531763.
164. Stieb S, Mohamed ASR, Deshpande TS, Harp J, Greiner B, Garden AS, Goepfert RP, Cardoso R, Ferrarotto R, Phan J, Reddy JP, Morrison WH, Rosenthal DI, Frank SJ, Fuller CD, Brandon Gunn G, MD Anderson Head and Neck Cancer Symptom Working Group. Prospective observational evaluation of radiation-induced late taste impairment kinetics in oropharyngeal cancer patients: Potential for improvement over time?. Clin Transl Radiat Oncol 22:98-105, 2020. e-Pub 2020. PMID: 32373720.
165. Liu R, Elhalawani H, Radwan Mohamed AS, Elgohari B, Court L, Zhu H, Fuller CD. Stability analysis of CT radiomic features with respect to segmentation variation in oropharyngeal cancer. Clin Transl Radiat Oncol 21:11-18, 2020. e-Pub 2019. PMID: 31886423.
166. Stieb S, Kiser K, van Dijk L, Livingstone NR, Elhalawani H, Elgohari B, McDonald B, Ventura J, Mohamed ASR, Fuller CD. Imaging for Response Assessment in Radiation Oncology: Current and Emerging Techniques. Hematol Oncol Clin North Am 34(1):293-306, 2020. e-Pub 2019. PMID: 31739950.
167. Gunn GB, Mendoza TR, Garden AS, Wang XS, Shi Q, Morrison WH, Frank SJ, Phan J, Fuller CD, Chambers MS, Hanna EY, Lu C, Rosenthal DI, Cleeland CS. Minocycline for symptom reduction during radiation therapy for head and neck cancer: a randomized clinical trial. Support Care Cancer 28(1):261-269, 2020. e-Pub 2019. PMID: 31037378.
168. Tyler MA, Mohamed ASR, Smith JB, Aymard JM, Fuller CD, Phan J, Frank SJ, Ferrarotto R, Kupferman ME, Hanna EY, Gunn GB, Su SY. Long-term quality of life after definitive treatment of sinonasal and nasopharyngeal malignancies. Laryngoscope 130(1):86-93, 2020. e-Pub 2019. PMID: 30706478.
169. Mohamed ASR, Smith BD, Smith JB, Sevak P, Malek JS, Kanwar A, Browne T, Gunn GB, Garden AS, Frank SJ, Morrison WH, Phan J, Zafereo M, Skinner H, Lai SY, Hutcheson KA, Lewin JS, Hessel AE, Thekdi AA, Weber RS, Fuller CD, Rosenthal DI. Outcomes of carotid-sparing IMRT for T1 glottic cancer: Comparison with conventional radiation. Laryngoscope 130(1):146-153, 2020. e-Pub 2019. PMID: 30756394.
170. Bagley AF, Ye R, Garden AS, Gunn GB, Rosenthal DI, Fuller CD, Morrison WH, Phan J, Sturgis EM, Ferrarotto R, Wu R, Liu AY, Frank SJ. Xerostomia-related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother Oncol 142:133-139, 2020. e-Pub 2019. PMID: 31431373.
171. Heukelom J, Kantor ME, Mohamed ASR, Elhalawani H, Kocak-Uzel E, Lin T, Yang J, Aristophanous M, Rasch CR, Fuller CD, Sonke JJ. Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation. Radiother Oncol 142:100-106, 2020. e-Pub 2019. PMID: 31431381.
172. Mesko S, Wang H, Tung S, Wang C, Pasalic D, Chapman BV, Moreno AC, Reddy JP, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Fuller CD, Morrison W, Phan J. Estimating PTV margins in head and neck stereotactic ablative radiation therapy (SABR) through target site analysis of positioning and intrafractional accuracy. Int J Radiat Oncol Biol Phys 106(1):185-193, 2020. e-Pub 2019. PMID: 31580928.
173. Kang J, Thompson RF, Fuller CD, Camphausen KA, Gabriel PE, Thomas CR. In Regard to Wallner et al. Int J Radiat Oncol Biol Phys 106(1):217-218, 2020. PMID: 31836083.
174. Yang J, Mohamed ASR, Bahig H, Ding Y, Wang J, Ng SP, Lai S, Miller A, Hutcheson KA, Fuller CD, Joint Head and Neck Radiotherapy MRI Development Cooperative. Automatic registration of 2D MR cine images for swallowing motion estimation. PLoS One 15(2):e0228652, 2020. e-Pub 2020. PMID: 32045464.
175. Kamal M, Peeler CR, Yepes P, Mohamed ASR, Blanchard P, Frank S, Chen L, Jethanandani A, Kuruvilla R, Greiner B, Harp J, Granberry R, Mehta V, Rock C, Hutcheson K, Cardenas C, Gunn GB, Fuller C, Mirkovic D. Radiation-Induced Hypothyroidism After Radical Intensity Modulated Radiation Therapy for Oropharyngeal Carcinoma. Adv Radiat Oncol 5(1):111-119, 2020. e-Pub 2019. PMID: 32051897.
176. Stieb S, McDonald B, Gronberg M, Engeseth GM, He R, Fuller CD. Imaging for Target Delineation and Treatment Planning in Radiation Oncology: Current and Emerging Techniques. Hematol Oncol Clin North Am 33(6):963-975, 2019. e-Pub 2019. PMID: 31668214.
177. Hall WA, Paulson ES, van der Heide UA, Fuller CD, Raaymakers BW, Lagendijk JJW, Li XA, Jaffray DA, Dawson LA, Erickson B, Verheij M, Harrington KJ, Sahgal A, Lee P, Parikh PJ, Bassetti MF, Robinson CG, Minsky BD, Choudhury A, Tersteeg RJHA, Schultz CJ, MR Linac Atlantic Consortium and the ViewRay C2T2 Research Consortium. The transformation of radiation oncology using real-time magnetic resonance guidance: A review. Eur J Cancer 122:42-52, 2019. e-Pub 2019. PMID: 31614288.
178. Ng SP, Ajayi T, Schaefer AJ, Pollard C, Bahig H, Garden AS, Rosenthal DI, Gunn GB, Frank SJ, Phan J, Morrison WH, Johnson JM, Mohamed ASR, Sturgis EM, Fuller CD. Surveillance imaging for patients with head and neck cancer treated with definitive radiotherapy: A partially observed Markov decision process model. Cancer. e-Pub 2019. PMID: 31725906.
179. Wu RY, Liu AY, Williamson TD, Yang J, Wisdom PG, Zhu XR, Frank SJ, Fuller CD, Gunn GB, Gao S. Quantifying the accuracy of deformable image registration for cone-beam computed tomography with a physical phantom. J Appl Clin Med Phys 20(10):92-100, 2019. e-Pub 2019. PMID: 31541526.
180. Vapiwala N, Thomas CR, Grover S, Yap ML, Mitin T, Shulman LN, Gospodarowicz MK, Longo J, Petereit DG, Ennis RD, Hayman JA, Rodin D, Buchsbaum JC, Vikram B, Abdel-Wahab M, Epstein AH, Okunieff P, Goldwein J, Kupelian P, Weidhaas JB, Tucker MA, Boice JD, Fuller CD, Thompson RF, Trister AD, Formenti SC, Barcellos-Hoff MH, Jones J, Dharmarajan KV, Zietman AL, Coleman CN. Enhancing Career Paths for Tomorrow's Radiation Oncologists. Int J Radiat Oncol Biol Phys 105(1):52-63, 2019. e-Pub 2019. PMID: 31128144.
181. McCulloch MM, Anderson BM, Cazoulat G, Peterson CB, Mohamed ASR, Volpe S, Elhalawani H, Bahig H, Rigaud B, King JB, Ford AC, Fuller CD, Brock KK. Biomechanical modeling of neck flexion for deformable alignment of the salivary glands in head and neck cancer images. Phys Med Biol 64(17):175018, 2019. e-Pub 2019. PMID: 31269475.
182. Joint Head and Neck MRI-Radiotherapy Development Cooperative, Kiser K, Meheissen MAM, Mohamed ASR, Kamal M, Ng SP, Elhalawani H, Jethanandani A, He R, Ding Y, Rostom Y, Hegazy N, Bahig H, Garden A, Lai S, Phan J, Gunn GB, Rosenthal D, Frank S, Brock KK, Wang J, Fuller CD. Prospective quantitative quality assurance and deformation estimation of MRI-CT image registration in simulation of head and neck radiotherapy patients. Clin Transl Radiat Oncol 18:120-127, 2019. e-Pub 2019. PMID: 31341987.
183. Stieb S, Elgohari B, Fuller CD. Repetitive MRI of organs at risk in head and neck cancer patients undergoing radiotherapy. Clin Transl Radiat Oncol 18:131-139, 2019. e-Pub 2019. PMID: 31341989.
184. Wang JR, Zafereo ME, Dadu R, Ferrarotto R, Busaidy NL, Lu C, Ahmed S, Gule-Monroe MK, Williams MD, Sturgis EM, Goepfert RP, Gross ND, Lai SY, Gunn GB, Phan J, Rosenthal DI, Fuller CD, Morrison WH, Iyer P, Cabanillas ME. Complete surgical resection following neoadjuvant dabrafenib plus trametinib in BRAFV600E-mutated anaplastic thyroid carcinoma. Thyroid 29(8):1036-1043, 2019. e-Pub 2019. PMID: 31319771.
185. Zaid M, Bajaj N, Burrows H, Mathew R, Dai A, Wilke CT, Palasi S, Hergenrother R, Chung C, Fuller CD, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Andersen M, Otun A, Chambers MS, Koay EJ. Creating customized oral stents for head and neck radiotherapy using 3D scanning and printing. Radiat Oncol 14(1):148, 2019. e-Pub 2019. PMID: 31426824.
186. McCulloch MM, Lee C, Rosen BS, Kamp JD, Lockhart CM, Lee JY, Polan DF, Hawkins PG, Anderson CJR, Heukelom J, Sonke JJ, Fuller CD, Balter JM, Ten Haken RK, Eisbruch A, Brock KK. Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer. Pract Radiat Oncol 9(4):e422-e431, 2019. e-Pub 2019. PMID: 30836190.
187. Heukelom J, Fuller CD. Head and Neck Cancer Adaptive Radiation Therapy (ART): Conceptual Considerations for the Informed Clinician. Semin Radiat Oncol 29(3):258-273, 2019. PMID: 31027643.
188. Ng SP, Pollard C, Berends J, Ayoub Z, Kamal M, Garden AS, Bahig H, Cantor SB, Schaefer AJ, Ajayi T, Gunn GB, Frank SJ, Skinner H, Phan J, Morrison WH, Ferrarotto R, Johnson JM, Mohamed ASR, Lai SY, Hessel AC, Sturgis EM, Weber RS, Fuller CD, Rosenthal DI. Usefulness of surveillance imaging in patients with head and neck cancer who are treated with definitive radiotherapy. Cancer 125(11):1823-1829, 2019. e-Pub 2019. PMID: 30748005.
189. Ho JC, Fang P, Cardenas CE, Mohamed ASR, Fuller CD, Allen PK, Bhosale PR, Frumovitz MM, Jhingran A, Klopp AH. Volumetric assessment of apparent diffusion coefficient predicts outcome following chemoradiation for cervical cancer. Radiother Oncol 135:58-64, 2019. e-Pub 2019. PMID: 31015171.
190. Elhalawani H, Fuller CD, Thompson RF. The Potential and Pitfalls of Crowdsourced Algorithm Development in Radiation Oncology. JAMA Oncol 5(5):662-663, 2019. e-Pub 2019. PMID: 30998812.
191. Lin TA, Garden AS, Elhalawani H, Elgohari B, Jethanandani A, Ng SP, Mohamed AS, Frank SJ, Glisson BS, Debnam JM, Sturgis EM, Phan J, Reddy JP, Fuller CD, Morrison WH, Skinner HD, Rosenthal DI, Gunn GB. Radiographic retropharyngeal lymph node involvement in HPV-associated oropharyngeal carcinoma: Patterns of involvement and impact on patient outcomes. Cancer 125(9):1536-1546, 2019. e-Pub 2019. PMID: 30620385.
192. McClelland Iii S, Mitin T, Nabavizadeh N, Fuller CD, Thomas CR, Jaboin JJ. Use of the g-index for assessment of citation-based scholarly activity of United States radiation oncology residents and subsequent choice of academic versus private practice career. Rep Pract Oncol Radiother 24(3):294-297, 2019. e-Pub 2019. PMID: 31080366.
193. MD Anderson Head and Neck Cancer Symptom Working Group, Grant S, Kamal M, Mohamed ASR, Zaveri J, Barrow MP, Gunn GB, Lai SY, Lewin JS, Rosenthal DI, Wang XS, Fuller CD, Hutcheson KA. Single-item discrimination of quality-of-life-altering dysphagia among 714 long-term oropharyngeal cancer survivors: Comparison of patient-reported outcome measures of swallowing. Cancer 125(10):1654-1664, 2019. e-Pub 2019. PMID: 30633325.
194. Kamal M, Barrow MP, Lewin JS, Estrella A, Gunn GB, Shi Q, Hofstede TM, Rosenthal DI, Fuller CD, Hutcheson KA, MD Anderson Head and Neck Cancer Symptom Working Group. Modeling symptom drivers of oral intake in long-term head and neck cancer survivors. Support Care Cancer 27(4):1405-1415, 2019. e-Pub 2018. PMID: 30218187.
195. Zaorsky NG, Ahmed AA, Zhu J, Yoo SK, Fuller CD, Thomas CR, Choi M, Holliday EB. Industry Funding Is Correlated With Publication Productivity of US Academic Radiation Oncologists. J Am Coll Radiol 16(2):244-251, 2019. e-Pub 2018. PMID: 30219342.
196. Zhu Y, Mohamed ASR, Lai SY, Yang S, Kanwar A, Wei L, Kamal M, Sengupta S, Elhalawani H, Skinner H, Mackin DS, Shiao J, Messer J, Wong A, Ding Y, Zhang L, Court L, Ji Y, Fuller CD. Imaging-Genomic Study of Head and Neck Squamous Cell Carcinoma: Associations Between Radiomic Phenotypes and Genomic Mechanisms via Integration of The Cancer Genome Atlas and The Cancer Imaging Archive. JCO Clin Cancer Inform 3:1-9, 2019. PMID: 30730765.
197. Elhalawani H, Elgohari B, Lin TA, Mohamed ASR, Fitzgerald TJ, Laurie F, Ulin K, Kalpathy-Cramer J, Guerrero T, Holliday EB, Russo G, Patel A, Jones W, Walker GV, Awan M, Choi M, Dagan R, Mahmoud O, Shapiro A, Kong FS, Gomez D, Zeng J, Decker R, Spoelstra FOB, Gaspar LE, Kachnic LA, Thomas CR, Okunieff P, Fuller CD. An in-silico quality assurance study of contouring target volumes in thoracic tumors within a cooperative group setting. Clin Transl Radiat Oncol 15:83-92, 2019. e-Pub 2019. PMID: 30775563.
198. Thompson RF, Fuller CD, Berman AT, Aneja S, Thomas CR. Career Enrichment Opportunities at the Scientific Frontier in Radiation Oncology. JCO Clin Cancer Inform 3:1-4, 2019. PMID: 30817170.
199. Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Sci Rep 9(1):1322, 2019. e-Pub 2019. PMID: 30718585.
200. Wu RY, Liu AY, Wisdom P, Zhu XR, Frank SJ, Fuller CD, Gunn GB, Palmer MB, Wages CA, Gillin MT, Yang J. Characterization of a new physical phantom for testing rigid and deformable image registration. J Appl Clin Med Phys 20(1):145-153, 2019. e-Pub 2018. PMID: 30580471.
201. Ger RB, Meier JG, Pahlka RB, Gay S, Mumme R, Fuller CD, Li H, Howell RM, Layman RR, Stafford RJ, Zhou S, Mawlawi O, Court LE. Effects of alterations in positron emission tomography imaging parameters on radiomics features. PLoS One 14(9):e0221877, 2019. e-Pub 2019. PMID: 31487307.
202. Ger RB, Zhou S, Elgohari B, Elhalawani H, Mackin DM, Meier JG, Nguyen CM, Anderson BM, Gay C, Ning J, Fuller CD, Li H, Howell RM, Layman RR, Mawlawi O, Stafford RJ, Aerts H, Court LE. Radiomics features of the primary tumor fail to improve prediction of overall survival in large cohorts of CT- and PET-imaged head and neck cancer patients. PLoS One 14(9):e0222509, 2019. e-Pub 2019. PMID: 31536526.
203. Ng SP, Pollard C, Kamal M, Ayoub Z, Garden AS, Bahig H, Gunn GB, Frank SJ, Skinner HD, Phan J, Berends J, Morrison WH, Johnson JM, Ferrarotto R, Sturgis EM, Mohamed ASR, Lai SY, Fuller CD, Rosenthal DI. Risk of second primary malignancies in head and neck cancer patients treated with definitive radiotherapy. NPJ Precis Oncol 3:22, 2019. e-Pub 2019. PMID: 31583278.
204. Kiser KJ, Smith BD, Wang J, Fuller CD. "Après Mois, Le Déluge": Preparing for the Coming Data Flood in the MRI-Guided Radiotherapy Era. Front Oncol 9:983, 2019. e-Pub 2019. PMID: 31632914.
205. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, Lindsay WD, Aerts HJWL, Agrimson B, Deville C, Rosenthal SA, Yu JB, Thomas CR. Artificial intelligence in radiation oncology: A specialty-wide disruptive transformation?. Radiother Oncol 129(3):421-426, 2018. e-Pub 2018. PMID: 29907338.
206. Mays AC, Hanna EY, Ferrarotto R, Phan J, Bell D, Silver N, Mulcahy CF, Roberts D, Abdelmeguid ASA, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Su SY. Prognostic factors and survival in adenoid cystic carcinoma of the sinonasal cavity. Head Neck 40(12):2596-2605, 2018. e-Pub 2018. PMID: 30447126.
207. Zdilar L, Vock DM, Marai GE, Fuller CD, Mohamed ASR, Elhalawani H, Elgohari BA, Tiras C, Miller A, Canahuate G. Evaluating the Effect of Right-Censored End Point Transformation for Radiomic Feature Selection of Data From Patients With Oropharyngeal Cancer. JCO Clin Cancer Inform 2:1-19, 2018. PMID: 30652615.
208. Ng SP, Johnson JM, Gunn GB, Rosenthal DI, Skinner HD, Phan J, Frank SJ, Morrison W, Sturgis EM, Mott FE, Williams MD, Fuller CD, Garden AS. Significance of Negative Posttreatment 18-FDG PET/CT Imaging in Patients With p16/HPV-Positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 102(4):1029-1035, 2018. e-Pub 2018. PMID: 29960060.
209. Heah H, Goepfert RP, Hutcheson KA, Garden AS, Gunn GB, Fuller CD, Lewin JS, Kupferman ME, Holsinger FC, Hessel AC, Gross ND. Decreased gastrostomy tube incidence and weight loss after transoral robotic surgery for low- to intermediate-risk oropharyngeal squamous cell carcinoma. Head Neck 40(11):2507-2513, 2018. e-Pub 2018. PMID: 30102824.
210. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, Lindsay WD, Aerts HJWL, Agrimson B, Deville C, Rosenthal SA, Yu JB, Thomas CR. Artificial Intelligence in Radiation Oncology Imaging. Int J Radiat Oncol Biol Phys 102(4):1159-1161, 2018. e-Pub 2018. PMID: 30353870.
211. Ger RB, Craft DF, Mackin DS, Zhou S, Layman RR, Jones AK, Elhalawani H, Fuller CD, Howell RM, Li H, Stafford RJ, Court LE. Practical guidelines for handling head and neck computed tomography artifacts for quantitative image analysis. Comput Med Imaging Graph 69:134-139, 2018. e-Pub 2018. PMID: 30268005.
212. Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD. Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial. Clin Transl Radiat Oncol 13:19-23, 2018. e-Pub 2018. PMID: 30386824.
213. Cardenas CE, Anderson BM, Aristophanous M, Yang J, Rhee DJ, McCarroll RE, Mohamed ASR, Kamal M, Elgohari BA, Elhalawani HM, Fuller CD, Rao A, Garden AS, Court LE. Auto-delineation of oropharyngeal clinical target volumes using 3D convolutional neural networks. Phys Med Biol 63(21):215026, 2018. e-Pub 2018. PMID: 30403188.
214. Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Author Correction: Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5(1):1, 2018. e-Pub 2018. PMID: 30482902.
215. Matuszak MM, Fuller CD, Yock TI, Hess CB, McNutt T, Jolly S, Gabriel P, Mayo CS, Thor M, Caissie A, Rao A, Owen D, Smith W, Palta J, Kapoor R, Hayman J, Waddle M, Rosenstein B, Miller R, Choi S, Moreno A, Herman J, Feng M. Performance/outcomes data and physician process challenges for practical big data efforts in radiation oncology. Med Phys 45(10):e811-e819, 2018. e-Pub 2018. PMID: 30229946.
216. Thompson RF, Valdes G, Fuller CD, Carpenter CM, Morin O, Aneja S, Lindsay WD, Aerts HJWL, Agrimson B, Deville C, Rosenthal SA, Yu JB, Thomas CR. The Future of Artificial Intelligence in Radiation Oncology. Int J Radiat Oncol Biol Phys 102(2):247-248, 2018. e-Pub 2018. PMID: 30191856.
217. El Naqa I, Ruan D, Valdes G, Dekker A, McNutt T, Ge Y, Wu QJ, Oh JH, Thor M, Smith W, Rao A, Fuller CD, Xiao Y, Manion F, Schipper M, Mayo C, Moran JM, Ten Haken R. Machine learning and modeling: Data, validation, communication challenges. Med Phys 45(10):e834-e840, 2018. e-Pub 2018. PMID: 30144098.
218. Multidisciplinary Larynx Cancer Working Group, Mulcahy CF, Mohamed ASR, Kanwar A, Hutcheson KA, Ghosh A, Vock D, Weber RS, Lai SY, Gunn GB, Zafereo M, Morrison WH, Ferrarotto R, Garden AS, Rosenthal DI, Fuller CD. Age-adjusted comorbidity and survival in locally advanced laryngeal cancer. Head Neck 40(9):2060-2069, 2018. e-Pub 2018. PMID: 29756307.
219. Kamal M, Mohamed ASR, Volpe S, Zaveri J, Barrow MP, Gunn GB, Lai SY, Ferrarotto R, Lewin JS, Rosenthal DI, Jethanandani A, Meheissen MAM, Mulder SL, Cardenas CE, Fuller CD, Hutcheson KA, MD Anderson Head, Neck Cancer Symptom Working Group. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry. Radiother Oncol 128(3):442-451, 2018. e-Pub 2018. PMID: 29961581.
220. Grossberg AJ, Mohamed ASR, Elhalawani H, Bennett WC, Smith KE, Nolan TS, Williams B, Chamchod S, Heukelom J, Kantor ME, Browne T, Hutcheson KA, Gunn GB, Garden AS, Morrison WH, Frank SJ, Rosenthal DI, Freymann JB, Fuller CD. Imaging and clinical data archive for head and neck squamous cell carcinoma patients treated with radiotherapy. Sci Data 5:180173, 2018. e-Pub 2018. PMID: 30179230.
221. Ng SP, Bahig H, Wang J, Cardenas CE, Lucci A, Hall CS, Meas S, Sarli VN, Yuan Y, Urbauer DL, Ding Y, Ikner S, Dinh V, Elgohari BA, Johnson JM, Skinner HD, Gunn GB, Garden AS, Phan J, Rosenthal DI, Morrison WH, Frank SJ, Hutcheson KA, Mohamed ASR, Lai SY, Ferrarotto R, MacManus MP, Fuller CD. Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling. BMC Cancer 18(1):903, 2018. e-Pub 2018. PMID: 30231854.
222. Tam S, Sandulache VC, Metwalli KA, Rock CD, Eraj SA, Sheu T, El-Naggar AK, Fuller CD, Weber RS, Lai SY. Incompletely treated malignancies of the major salivary gland: Toward evidence-based care. Head Neck 40(8):1630-1638, 2018. e-Pub 2018. PMID: 29734482.
223. Jones KM, Michel KA, Bankson JA, Fuller CD, Klopp AH, Venkatesan AM. Emerging Magnetic Resonance Imaging Technologies for Radiation Therapy Planning and Response Assessment. Int J Radiat Oncol Biol Phys 101(5):1046-1056, 2018. e-Pub 2018. PMID: 30012524.
224. Ger RB, Zhou S, Chi PM, Lee HJ, Layman RR, Jones AK, Goff DL, Fuller CD, Howell RM, Li H, Stafford RJ, Court LE, Mackin DS. Comprehensive Investigation on Controlling for CT Imaging Variabilities in Radiomics Studies. Sci Rep 8(1):13047, 2018. e-Pub 2018. PMID: 30158540.
225. Pezzi TA, Schwartz DL, Mohamed ASR, Welsh JW, Komaki RU, Hahn SM, Sepesi B, Pezzi CM, Fuller CD, Chun SG. Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer. JAMA Oncol 4(8):e174504, 2018. e-Pub 2018. PMID: 29302695.
226. Ng SP, Dyer BA, Kalpathy-Cramer J, Mohamed ASR, Awan MJ, Gunn GB, Phan J, Zafereo M, Debnam JM, Lewis CM, Colen RR, Kupferman ME, Guha-Thakurta N, Canahuate G, Marai GE, Vock D, Hamilton B, Holland J, Cardenas CE, Lai S, Rosenthal D, Fuller CD. A prospective in silico analysis of interdisciplinary and interobserver spatial variability in post-operative target delineation of high-risk oral cavity cancers: Does physician specialty matter?. Clin Transl Radiat Oncol 12:40-46, 2018. e-Pub 2018. PMID: 30148217.
227. López Alfonso JC, Parsai S, Joshi N, Godley A, Shah C, Koyfman SA, Caudell JJ, Fuller CD, Enderling H, Scott JG. Temporally feathered intensity modulated radiation therapy: a planning technique to reduce normal tissue toxicity. Med Phys 45(7):3466-3474, 2018. e-Pub 2018. PMID: 29786861.
228. Ger RB, Yang J, Ding Y, Jacobsen MC, Cardenas CE, Fuller CD, Howell RM, Li H, Stafford RJ, Zhou S, Court LE. Synthetic head and neck and phantom images for determining deformable image registration accuracy in magnetic resonance imaging. Med Phys. e-Pub 2018. PMID: 30007075.
229. Mays AC, Bell D, Ferrarotto R, Phan J, Roberts D, Fuller CD, Frank SJ, Raza SM, Kupferman ME, DeMonte F, Hanna EY, Su SY. Early Stage olfactory neuroblastoma and the impact of resecting dura and olfactory bulb. Laryngoscope 128(6):1274-1280, 2018. e-Pub 2017. PMID: 29226334.
230. Cardenas CE, McCarroll RE, Court LE, Elgohari BA, Elhalawani H, Fuller CD, Kamal MJ, Meheissen MAM, Mohamed ASR, Rao A, Williams B, Wong A, Yang J, Aristophanous M. Deep Learning Algorithm for Auto-Delineation of High-Risk Oropharyngeal Clinical Target Volumes With Built-In Dice Similarity Coefficient Parameter Optimization Function. Int J Radiat Oncol Biol Phys 101(2):468-478, 2018. e-Pub 2018. PMID: 29559291.
231. Kieselmann JP, Kamerling CP, Burgos N, Menten MJ, Fuller CD, Nill S, Cardoso MJ, Oelfke U. Geometric and dosimetric evaluations of atlas-based segmentation methods of MR images in the head and neck region. Phys Med Biol. e-Pub 2018. PMID: 29882749.
232. Pinnix CC, Ng AK, Dabaja BS, Milgrom SA, Gunther JR, Fuller CD, Smith GL, Abou Yehia Z, Qiao W, Wogan CF, Akhtari M, Mawlawi O, Medeiros LJ, Chuang HH, Martin-Doyle W, Armand P, LaCasce AS, Oki Y, Fanale M, Westin J, Neelapu S, Nastoupil L. Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Adv 2(11):1334-1343, 2018. PMID: 29895624.
233. Mohamed ASR, Bahig H, Aristophanous M, Blanchard P, Kamal M, Ding Y, Cardenas CE, Brock KK, Lai SY, Hutcheson KA, Phan J, Wang J, Ibbott G, Gabr RE, Narayana PA, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, MD Anderson MRLinac Development Working Group. Prospective in silico study of the feasibility and dosimetric advantages of MRI-guided dose adaptation for human papillomavirus positive oropharyngeal cancer patients compared with standard IMRT. Clin Transl Radiat Oncol 11:11-18, 2018. e-Pub 2018. PMID: 30014042.
234. Hutcheson KA, Barrow MP, Plowman EK, Lai SY, Fuller CD, Barringer DA, Eapen G, Wang Y, Hubbard R, Jimenez SK, Little LG, Lewin JS. Expiratory muscle strength training for radiation-associated aspiration after head and neck cancer: A case series. Laryngoscope 128(5):1044-1051, 2018. e-Pub 2017. PMID: 28833185.
235. Goepfert RP, Lewin JS, Barrow MP, Warneke CL, Fuller CD, Lai SY, Weber RS, Hutcheson KA. Grading Dysphagia as a Toxicity of Head and Neck Cancer: Differences in Severity Classification Based on MBS DIGEST and Clinical CTCAE Grades. Dysphagia 33(2):185-191, 2018. e-Pub 2017. PMID: 28836005.
236. Kamal M, Mohamed ASR, Fuller CD, Sturgis EM, Johnson FM, Morrison WH, Gunn GB, Hutcheson KA, Phan J, Volpe S, Ng SP, Ferrarotto R, Frank SJ, Skinner HD, Rosenthal DI, Garden AS. Outcomes of patients diagnosed with carcinoma metastatic to the neck from an unknown primary source and treated with intensity-modulated radiation therapy. Cancer 124(7):1415-1427, 2018. e-Pub 2018. PMID: 29338089.
237. Kamal M, Ng SP, Eraj SA, Rock CD, Pham B, Messer JA, Garden AS, Morrison WH, Phan J, Frank SJ, El-Naggar AK, Johnson JM, Ginsberg LE, Ferrarotto R, Lewin JS, Hutcheson KA, Cardenas CE, Zafereo ME, Lai SY, Hessel AC, Weber RS, Gunn GB, Fuller CD, Mohamed ASR, Rosenthal DI. Three-dimensional imaging assessment of anatomic invasion and volumetric considerations for chemo/radiotherapy-based laryngeal preservation in T3 larynx cancer. Oral Oncol 79:1-8, 2018. e-Pub 2018. PMID: 29598944.
238. Yan Y, Yang J, Beddar S, Ibbott G, Wen Z, Court LE, Hwang KP, Kadbi M, Krishnan S, Fuller CD, Frank SJ, Yang J, Balter P, Kudchadker RJ, Wang J. A methodology to investigate the impact of image distortions on the radiation dose when using magnetic resonance images for planning. Phys Med Biol 63(8):085005, 2018. e-Pub 2018. PMID: 29528037.
239. Phan J, Pollard C, Brown PD, Guha-Thakurta N, Garden AS, Rosenthal DI, Fuller CD, Frank SJ, Gunn GB, Morrison WH, Ho JC, Li J, Ghia AJ, Yang JN, Luo D, Wang HC, Su SY, Raza SM, Gidley PW, Hanna EY, DeMonte F. Stereotactic radiosurgery for trigeminal pain secondary to recurrent malignant skull base tumors. J Neurosurg 130(3):1-10, 2018. e-Pub 2018. PMID: 29701557.
240. Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol 28(2):108-113, 2018. PMID: 29735186.
241. Rock CB, Prabhu AV, Fuller CD, Thomas CR, Holliday EB. Evaluation of the Relative Citation Ratio, a New National Institutes of Health-Supported Bibliometric Measure of Research Productivity, among Academic Radiation Oncologists. J Am Coll Radiol 15(3 Pt A):469-474, 2018. e-Pub 2018. PMID: 29301726.
242. Mayo CS, Moran JM, Bosch W, Xiao Y, McNutt T, Popple R, Michalski J, Feng M, Marks LB, Fuller CD, Yorke E, Palta J, Gabriel PE, Molineu A, Matuszak MM, Covington E, Masi K, Richardson SL, Ritter T, Morgas T, Flampouri S, Santanam L, Moore JA, Purdie TG, Miller RC, Hurkmans C, Adams J, Jackie Wu QR, Fox CJ, Siochi RA, Brown NL, Verbakel W, Archambault Y, Chmura SJ, Dekker AL, Eagle DG, Fitzgerald TJ, Hong T, Kapoor R, Lansing B, Jolly S, Napolitano ME, Percy J, Rose MS, Siddiqui S, Schadt C, Simon WE, Straube WL, St James ST, Ulin K, Yom SS, Yock TI. American Association of Physicists in Medicine Task Group 263: Standardizing Nomenclatures in Radiation Oncology. Int J Radiat Oncol Biol Phys 100(4):1057-1066, 2018. e-Pub 2017. PMID: 29485047.
243. Steinmann A, Stafford RJ, Sawakuchi G, Wen Z, Court L, Fuller CD, Followill D. Developing and characterizing MR/CT-visible materials used in QA phantoms for MRgRT systems. Med Phys 45(2):773-782, 2018. e-Pub 2017. PMID: 29178486.
244. MD Anderson Head and Neck Cancer Symptom Working Group, Kamal M, Rosenthal DI, Volpe S, Goepfert RP, Garden AS, Hutcheson KA, Al Feghali KA, Meheissen MAM, Eraj SA, Dursteler AE, Williams B, Smith JB, Aymard JM, Berends J, White AL, Frank SJ, Morrison WH, Cardoso R, Chambers MS, Sturgis EM, Mendoza TR, Lu C, Mohamed ASR, Fuller CD, Gunn GB. Patient reported dry mouth: Instrument comparison and model performance for correlation with quality of life in head and neck cancer survivors. Radiother Oncol 126(1):75-80, 2018. e-Pub 2017. PMID: 29229507.
245. Jethanandani A, Lin TA, Volpe S, Elhalawani H, Mohamed ASR, Yang P, Fuller CD. Exploring Applications of Radiomics in Magnetic Resonance Imaging of Head and Neck Cancer: A Systematic Review. Front Oncol 8:131, 2018. e-Pub 2018. PMID: 29868465.
246. Elhalawani H, Lin TA, Volpe S, Mohamed ASR, White AL, Zafereo J, Wong AJ, Berends JE, AboHashem S, Williams B, Aymard JM, Kanwar A, Perni S, Rock CD, Cooksey L, Campbell S, Yang P, Nguyen K, Ger RB, Cardenas CE, Fave XJ, Sansone C, Piantadosi G, Marrone S, Liu R, Huang C, Yu K, Li T, Yu Y, Zhang Y, Zhu H, Morris JS, Baladandayuthapani V, Shumway JW, Ghosh A, Pöhlmann A, Phoulady HA, Goyal V, Canahuate G, Marai GE, Vock D, Lai SY, Mackin DS, Court LE, Freymann J, Farahani K, Kaplathy-Cramer J, Fuller CD. Machine Learning Applications in Head and Neck Radiation Oncology: Lessons From Open-Source Radiomics Challenges. Front Oncol 8:294, 2018. e-Pub 2018. PMID: 30175071.
247. Zhou Q, Zeng F, Ding Y, Fuller CD, Wang J. Meta-analysis of diffusion-weighted imaging for predicting locoregional failure of chemoradiotherapy in patients with head and neck squamous cell carcinoma. Mol Clin Oncol 8(1):197-203, 2018. e-Pub 2017. PMID: 29423223.
248. Dextraze K, Saha A, Kim D, Narang S, Lehrer M, Rao A, Narang S, Rao D, Ahmed S, Madhugiri V, Fuller CD, Kim MM, Krishnan S, Rao G, Rao A. Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma. Oncotarget 8(68):112992-113001, 2017. e-Pub 2017. PMID: 29348883.
249. Goepfert RP, Fuller CD, Gunn GB, Hanna EY, Lewin JS, Zaveri JS, Hubbard RM, Barrow MP, Hutcheson KA. Symptom burden as a driver of decisional regret in long-term oropharyngeal carcinoma survivors. Head Neck 39(11):2151-2158, 2017. e-Pub 2017. PMID: 28736965.
250. MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Brandon Gunn G. Correction to: Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):186, 2017. e-Pub 2017. PMID: 29169353.
251. Ger RB, Yang J, Ding Y, Jacobsen MC, Fuller CD, Howell RM, Li H, Jason Stafford R, Zhou S, Court LE. Accuracy of deformable image registration on magnetic resonance images in digital and physical phantoms. Med Phys 44(10):5153-5161, 2017. e-Pub 2017. PMID: 28622410.
252. Pollard C, Nguyen TP, Ng SP, Frank SJ, Garden AS, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Shah SJ, Wang H, Tung S, Wang C, Ginsberg LD, Zafereo ME, Sturgis EM, Su SY, Hanna EY, Rosenthal DI, Phan J. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck 39(10):2079-2087, 2017. e-Pub 2017. PMID: 28741749.
253. Hansen CC, Smith JB, Mohamed ASR, Mulcahy CF, Wefel JS, Hutcheson KA, Chrane K, Phan J, Frank SJ, Garden AS, Smith BD, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Lewis CM, Kupferman ME, Johnson JM, Skinner HD, Lai SY, Hanna EY, Rosenthal DI, Fuller CD, Gunn GB, MD Anderson Head and Neck Cancer Symptom Working Group. Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module. Head Neck 39(10):2048-2056, 2017. e-Pub 2017. PMID: 28763137.
254. Quinlan-Davidson SR, Mohamed ASR, Myers JN, Gunn GB, Johnson FM, Skinner H, Beadle BM, Gillenwater AM, Phan J, Frank SJ, William WN, Wong AJ, Lai SY, Fuller CD, Morrison WH, Rosenthal DI, Garden AS. Outcomes of oral cavity cancer patients treated with surgery followed by postoperative intensity modulated radiation therapy. Oral Oncol 72:90-97, 2017. e-Pub 2017. PMID: 28797467.
255. MD Anderson Head and Neck Cancer Symptom Working Group, Eraj SA, Jomaa MK, Rock CD, Mohamed ASR, Smith BD, Smith JB, Browne T, Cooksey LC, Williams B, Temple B, Preston KE, Aymard JM, Gross ND, Weber RS, Hessel AC, Ferrarotto R, Phan J, Sturgis EM, Hanna EY, Frank SJ, Morrison WH, Goepfert RP, Lai SY, Rosenthal DI, Mendoza TR, Cleeland CS, Hutcheson KA, Fuller CD, Garden AS, Gunn GB. Long-term patient reported outcomes following radiation therapy for oropharyngeal cancer: cross-sectional assessment of a prospective symptom survey in patients =65 years old. Radiat Oncol 12(1):150, 2017. e-Pub 2017. PMID: 28888224.
256. Ger RB, Mohamed ASR, Awan MJ, Ding Y, Li K, Fave XJ, Beers AL, Driscoll B, Elhalawani H, Hormuth DA, Houdt PJV, He R, Zhou S, Mathieu KB, Li H, Coolens C, Chung C, Bankson JA, Huang W, Wang J, Sandulache VC, Lai SY, Howell RM, Stafford RJ, Yankeelov TE, Heide UAV, Frank SJ, Barboriak DP, Hazle JD, Court LE, Kalpathy-Cramer J, Fuller CD. A Multi-Institutional Comparison of Dynamic Contrast-Enhanced Magnetic Resonance Imaging Parameter Calculations. Sci Rep 7(1):11185, 2017. e-Pub 2017. PMID: 28894197.
257. Holliday EB, Bonner JA, Formenti SC, Hahn SM, Kalnicki S, Liu FF, Movsas B, Fuller CD, Thomas CR. Emotional Intelligence and Burnout in Academic Radiation Oncology Chairs. J Healthc Manag 62(5):302-313, 2017. PMID: 28885530.
258. Mesa Linares F, Papanikolaou N, Esquivel C, Eng TY, Fuller CD, Sosa M. Prescribed and Measured Dose Differences for an AP-PA TBI Protocol with Compensation Filter and Ergonomic Patient Support. J Med Imaging Radiat Sci 48(3):301-306, 2017. e-Pub 2017. PMID: 31047414.
259. Hutcheson KA, Yuk M, Hubbard R, Gunn GB, Fuller CD, Lai SY, Lin H, Garden AS, Rosenthal DI, Hanna EY, Kies MS, Lewin JS. Delayed lower cranial neuropathy after oropharyngeal intensity-modulated radiotherapy: A cohort analysis and literature review. Head Neck 39(8):1516-1523, 2017. e-Pub 2017. PMID: 28452175.
260. Shiao JC, Mohamed ASR, Messer JA, Hutcheson KA, Johnson JM, Enderling H, Kamal M, Warren BW, Pham B, Morrison WH, Zafereo ME, Hessel AC, Lai SY, Kies MS, Ferrarotto R, Garden AS, Schomer DF, Gunn GB, Phan J, Frank SJ, Beadle BM, Weber RS, Lewin JS, Rosenthal DI, Fuller CD. Quantitative pretreatment CT volumetry: Association with oncologic outcomes in patients with T4a squamous carcinoma of the larynx. Head Neck 39(8):1609-1620, 2017. e-Pub 2017. PMID: 28464542.
261. Mohamed ASR, Cardenas CE, Garden AS, Awan MJ, Rock CD, Westergaard SA, Brandon Gunn G, Belal AM, El-Gowily AG, Lai SY, Rosenthal DI, Fuller CD, Aristophanous M. Patterns-of-failure guided biological target volume definition for head and neck cancer patients: FDG-PET and dosimetric analysis of dose escalation candidate subregions. Radiother Oncol 124(2):248-255, 2017. e-Pub 2017. PMID: 28774596.
262. Rosenthal DI, Mohamed ASR, Garden AS, Morrison WH, El-Naggar AK, Kamal M, Weber RS, Fuller CD, Peters LJ. Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer. Int J Radiat Oncol Biol Phys 98(5):1002-1011, 2017. e-Pub 2017. PMID: 28721881.
263. Mohamed ASR, Wong AJ, Fuller CD, Kamal M, Gunn GB, Phan J, Morrison WH, Beadle BM, Skinner H, Lai SY, Quinlan-Davidson SR, Belal AM, El-Gowily AG, Frank SJ, Rosenthal DI, Garden AS. Patterns of locoregional failure following post-operative intensity-modulated radiotherapy to oral cavity cancer: quantitative spatial and dosimetric analysis using a deformable image registration workflow. Radiat Oncol 12(1):129, 2017. e-Pub 2017. PMID: 28806994.
264. Cardenas CE, Mohamed ASR, Tao R, Wong AJR, Awan MJ, Kuruvila S, Aristophanous M, Gunn GB, Phan J, Beadle BM, Frank SJ, Garden AS, Morrison WH, Fuller CD, Rosenthal DI. Prospective Qualitative and Quantitative Analysis of Real-Time Peer Review Quality Assurance Rounds Incorporating Direct Physical Examination for Head and Neck Cancer Radiation Therapy. Int J Radiat Oncol Biol Phys 98(3):532-540, 2017. e-Pub 2016. PMID: 28258898.
265. Taylor EN, Ding Y, Zhu S, Cheah E, Alexander P, Lin L, Aninwene GE, Hoffman MP, Mahajan A, Mohamed ASR, McDannold N, Fuller CD, Chen CC, Gilbert RJ. Association between tumor architecture derived from generalized Q-space MRI and survival in glioblastoma. Oncotarget 8(26):41815-41826, 2017. PMID: 28404971.
266. Zhang W, Zhang X, Yang P, Blanchard P, Garden AS, Gunn B, Fuller CD, Chambers M, Hutcheson KA, Ye R, Lai SY, Radwan MAS, Zhu XR, Frank SJ. Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer. Radiother Oncol 123(3):401-405, 2017. e-Pub 2017. PMID: 28549794.
267. Pezzi TA, Mohamed ASR, Sheu T, Blanchard P, Sandulache VC, Lai SY, Cabanillas ME, Williams MD, Pezzi CM, Lu C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base. Cancer 123(9):1653-1661, 2017. e-Pub 2016. PMID: 28026871.
268. Pezzi TA, Mohamed AS, Fuller CD, Blanchard P, Pezzi C, Sepesi B, Hahn SM, Gomez DR, Chun SG. Radiation Therapy is Independently Associated with Worse Survival After R0-Resection for Stage I-II Non-small Cell Lung Cancer: An Analysis of the National Cancer Data Base. Ann Surg Oncol 24(5):1419-1427, 2017. e-Pub 2017. PMID: 28154950.
269. Goepfert RP, Lewin JS, Barrow MP, Fuller CD, Lai SY, Song J, Hobbs BP, Gunn GB, Beadle BM, Rosenthal DI, Garden AS, Kies MS, Papadimitrakopoulou VA, Schwartz DL, Hutcheson KA. Predicting two-year longitudinal MD Anderson Dysphagia Inventory outcomes after intensity modulated radiotherapy for locoregionally advanced oropharyngeal carcinoma. Laryngoscope 127(4):842-848, 2017. e-Pub 2016. PMID: 27440393.
270. Quinlan-Davidson SR, Morrison WH, Myers JN, Gunn GB, William WN, Beadle BM, Skinner HD, Gillenwater AM, Frank SJ, Phan J, Johnson FM, Fuller CD, Zafereo ME, Rosenthal DI, Garden AS. Recurrent oral cavity cancer: Patterns of failure after salvage multimodality therapy. Head Neck 39(4):633-638, 2017. e-Pub 2016. PMID: 28006086.
271. Ho JC, Allen PK, Bhosale PR, Rauch GM, Fuller CD, Mohamed AS, Frumovitz M, Jhingran A, Klopp AH. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Int J Radiat Oncol Biol Phys 97(3):546-553, 2017. e-Pub 2016. PMID: 28011045.
272. Wong ATT, Lai SY, Gunn GB, Beadle BM, Fuller CD, Barrow MP, Hofstede TM, Chambers MS, Sturgis EM, Mohamed ASR, Lewin JS, Hutcheson KA. Symptom burden and dysphagia associated with osteoradionecrosis in long-term oropharynx cancer survivors: A cohort analysis. Oral Oncol 66:75-80, 2017. e-Pub 2017. PMID: 28249651.
273. Multidisciplinary Larynx Cancer Working Group. Conditional Survival Analysis of Patients With Locally Advanced Laryngeal Cancer: Construction of a Dynamic Risk Model and Clinical Nomogram. Sci Rep 7:43928, 2017. e-Pub 2017. PMID: 28276466.
274. Sandulache VC, Chen Y, Feng L, William WN, Skinner HD, Myers JN, Meyn RE, Li J, Mijiti A, Bankson JA, Fuller CD, Konopleva MY, Lai SY. Metabolic interrogation as a tool to optimize chemotherapeutic regimens. Oncotarget 8(11):18154-18165, 2017. PMID: 28184025.
275. Hutcheson KA, Barrow MP, Barringer DA, Knott JK, Lin HY, Weber RS, Fuller CD, Lai SY, Alvarez CP, Raut J, Lazarus CL, May A, Patterson J, Roe JW, Starmer HM, Lewin JS. Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation. Cancer 123(1):62-70, 2017. e-Pub 2016. PMID: 27564246.
276. Chen DW, Lewin JS, Xu L, Lai SY, Gunn GB, Fuller CD, Mohamed AS, Kanwar A, Sturgis EM, Hutcheson KA. Feeding Tube Utilization in Patients with Salivary Gland Malignancies. Otolaryngol Head Neck Surg 156(1):109-117, 2017. e-Pub 2016. PMID: 27576681.
277. Zhang C, Murata S, Murata M, Fuller CD, Thomas CR, Choi M, Holliday EB. Factors associated with increased academic productivity among US academic radiation oncology faculty. Pract Radiat Oncol 7(1):e59-e64, 2017. e-Pub 2016. PMID: 27637135.
278. Verkooijen HM, Kerkmeijer LGW, Fuller CD, Huddart R, Faivre-Finn C, Verheij M, Mook S, Sahgal A, Hall E, Schultz C. R-IDEAL: A Framework for Systematic Clinical Evaluation of Technical Innovations in Radiation Oncology. Front Oncol 7:59, 2017. e-Pub 2017. PMID: 28421162.
279. Wilke CT, Zaid M, Chung C, Fuller CD, Mohamed ASR, Skinner H, Phan J, Gunn GB, Morrison WH, Garden AS, Frank SJ, Rosenthal DI, Chambers MS, Koay EJ. Design and fabrication of a 3D-printed oral stent for head and neck radiotherapy from routine diagnostic imaging. 3D Print Med 3(1):12, 2017. e-Pub 2017. PMID: 29782600.
280. Fuller CD, Mohamed AS, Garden AS, Gunn GB, Mulcahy CF, Zafereo M, Phan J, Lai SY, Lewin JS, Hutcheson KA, Frank SJ, Beadle BM, Morrison WH, El-Naggar AK, Kocak-Uzel E, Ginsberg LE, Kies MS, Weber RS, Rosenthal DI. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches. Head Neck 38(12):1739-1751, 2016. e-Pub 2016. PMID: 27466789.
281. Blanchard P, Wong AJ, Gunn GB, Garden AS, Mohamed AS, Rosenthal DI, Crutison J, Wu R, Zhang X, Zhu XR, Mohan R, Amin MV, Fuller CD, Frank SJ. Toward a model-based patient selection strategy for proton therapy: External validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort. Radiother Oncol 121(3):381-386, 2016. e-Pub 2016. PMID: 27641784.
282. Perni S, Mohamed AS, Scott J, Enderling H, Garden AS, Gunn GB, Rosenthal DI, Fuller CD. CT-based volumetric tumor growth velocity: A novel imaging prognostic indicator in oropharyngeal cancer patients receiving radiotherapy. Oral Oncol 63:16-22, 2016. e-Pub 2016. PMID: 27938995.
283. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Reply to radiotherapy for human papillomavirus-positive oropharyngeal cancers in the National Cancer Data Base. Cancer 122(21):3411-3412, 2016. e-Pub 2016. PMID: 27420634.
284. Sheu T, Garden AS, Fuller CD, Gunn GB, Nguyen T, Beadle BM, Morrison WH, Sio TT, Takiar V, Zafereo M, Rosenthal DI, Frank SJ, Phan J. Reirradiation Utilizing Proton Radiation Therapy May Improve Toxicity Free Survival in Patients With Small-Volume, Recurrent Head And Neck Cancer. Int J Radiat Oncol Biol Phys 96(2S):E331, 2016. PMID: 27674401.
285. Shiao JC, Mohamed AS, Gunn GB, Hutcheson KA, Kanwar A, Garden AS, Smith J, Phan J, Morrison WH, Lai SY, Beadle BM, Weber RS, Kies MS, Rosenthal DI, Fuller CD. Nontarget Swallowing Muscles Dose-Volume Correlates of Patient-Reported Outcomes After Oropharyngeal Intensity Modulated Radiation Therapy (IMRT). Int J Radiat Oncol Biol Phys 96(2S):E335-E336, 2016. PMID: 27674409.
286. Perni S, Mohamed AS, Garden AS, Gunn GB, Rosenthal DI, Scott JG, Fuller CD. Pretreatment Computed Tomography-Based Volumetric Tumor Growth Velocity: A Novel Prognostic Indicator for Head and Neck Cancer. Int J Radiat Oncol Biol Phys 96(2S):E341-E342, 2016. PMID: 27674427.
287. Mohamed AS, Pham BH, Messer JA, Morrison WH, Zafereo M, Hessel AC, Lai SY, Garden AS, Weber RS, Rosenthal DI, Fuller CD. Identification of Anatomic Correlates of Failure in Patients With T4a Larynx Cancer. Int J Radiat Oncol Biol Phys 96(2S):E343, 2016. PMID: 27674433.
288. Pezzi TA, Mohamed AS, Sheu T, Blanchard P, Sandulache VC, Lai SY, Cabanillas ME, Williams MD, Pezzi CM, Lu C, Garden AS, Morrison WH, Rosenthal DI, Fuller CD, Gunn GB. Relationship Between Radiation Therapy Dose and Overall Survival in Anaplastic Thyroid Cancer: Analysis of the National Cancer Data Base. Int J Radiat Oncol Biol Phys 96(2S):E361, 2016. PMID: 27674482.
289. Campbell SR, Mohamed AS, Heukelom J, Awan MJ, Garden AS, Gunn GB, Rosenthal DI, Fuller CD. Primary Tumor Regression Index: The Prognostic Value of Volumetric Image Guided Radiation Therapy for Head and Neck Cancer. Int J Radiat Oncol Biol Phys 96(2S):E363-E364, 2016. PMID: 27674487.
290. Mohamed AS, Browne TS, Kies MS, Gunn GB, Garden AS, Beadle BM, Phan J, Morrison WH, William WN, Lai SY, Weber RS, Rosenthal DI, Fuller CD. Predictive Significance of Early Response to Induction Chemotherapy in Advanced Larynx Cancer. Int J Radiat Oncol Biol Phys 96(2S):E371-E372, 2016. PMID: 27674512.
291. Pollard C, Nguyen T, Garden AS, Frank SJ, Gunn GB, Fuller CD, Beadle BM, Morrison WH, Wang H, Tung S, Rosenthal DI, Phan J, Wang C. Clinical Outcomes After Local Field Reirradiation of Patients With Recurrent Retropharyngeal Nodal Metastasis. Int J Radiat Oncol Biol Phys 96(2S):E388, 2016. PMID: 27674555.
292. Phan J, Frank SJ, Chun S, Zhu XR, Tung S, Wang C, Zhang X, Crawford C, Garden AS, Rosenthal DI, Gunn GB, Nguyen QN, Fuller CD, Wang H. Evaluation of Intensity Modulated Proton Therapy for Stereotactic Ablative Radiation Therapy of Recurrent Skull Base Tumors: A Comparative Treatment Planning Study With Volumetric Modulated Arc Therapy. Int J Radiat Oncol Biol Phys 96(2S):E677, 2016. PMID: 27675333.
293. Kanwar A, Mohamed AS, Court LE, Zhang L, Marai GE, Canahuate G, Lee JS, Perni S, Messer JA, Pham BH, Youssef B, Vock D, Rao A, Kalpathy-Cramer J, Gunn GB, Rosenthal DI, Fuller CD. Development of a Predictive Quantitative Contrast Computed Tomography-Based Feature (Radiomics) Profile for Local Recurrence in Oropharyngeal Cancers. Int J Radiat Oncol Biol Phys 96(2S):S191, 2016. PMID: 27675753.
294. Mohamed AS, Lai SY, Murri M, Hutcheson KA, Sandulache VC, Hobbs B, Gunn GB, Garg N, Chambers MS, Frank SJ, Rosenthal DI, Garden AS, Fuller CD. Dose-Volume Correlates of Osteoradionecrosis of the Mandible in Oropharynx Patients Receiving Intensity Modulated Radiation Therapy. Int J Radiat Oncol Biol Phys 96(2S):S220-S221, 2016. PMID: 27675829.
295. Blanchard P, Wong AJ, Gunn GB, Garden AS, Mohamed AS, Rosenthal DI, Morrison WH, Skinner HD, Phan J, Beadle BM, Crutison J, Amin M, Mirkovic D, Zhang X, Zhu XR, Mohan R, Fuller CD, Frank SJ. Toward a Model-Based Strategy for Patient Selection for Proton Therapy-External Validation of Normal Tissue Complication Probability Models on a Head and Neck Proton Cohort. Int J Radiat Oncol Biol Phys 96(2S):S223, 2016. PMID: 27675837.
296. Chamchod S, Fuller CD, Mohamed AS, Grossberg A, Messer JA, Heukelom J, Gunn GB, Kantor ME, Eichelberger H, Garden AS, Rosenthal DI. Quantitative body mass characterization before and after head and neck cancer radiotherapy: A challenge of height-weight formulae using computed tomography measurement. Oral Oncol 61:62-9, 2016. e-Pub 2016. PMID: 27688106.
297. Phan J, Sio TT, Nguyen TP, Takiar V, Gunn GB, Garden AS, Rosenthal DI, Fuller CD, Morrison WH, Beadle B, Ma D, Zafereo ME, Hutcheson KA, Kupferman ME, William WN, Frank SJ. Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 96(1):30-41, 2016. e-Pub 2016. PMID: 27325480.
298. Sio TT, Lin HK, Shi Q, Gunn GB, Cleeland CS, Lee JJ, Hernandez M, Blanchard P, Thaker NG, Phan J, Rosenthal DI, Garden AS, Morrison WH, Fuller CD, Mendoza TR, Mohan R, Wang XS, Frank SJ. Intensity Modulated Proton Therapy Versus Intensity Modulated Photon Radiation Therapy for Oropharyngeal Cancer: First Comparative Results of Patient-Reported Outcomes. Int J Radiat Oncol Biol Phys 95(4):1107-14, 2016. e-Pub 2016. PMID: 27354125.
299. Takiar V, Garden AS, Ma D, Morrison WH, Edson M, Zafereo ME, Gunn GB, Fuller CD, Beadle B, Frank SJ, William WN, Kies M, El-Naggar AK, Weber R, Rosenthal DI, Phan J. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses. Int J Radiat Oncol Biol Phys 95(4):1117-31, 2016. e-Pub 2016. PMID: 27354127.
300. Weygand J, Fuller CD, Ibbott GS, Mohamed AS, Ding Y, Yang J, Hwang KP, Wang J. Spatial Precision in Magnetic Resonance Imaging-Guided Radiation Therapy: The Role of Geometric Distortion. Int J Radiat Oncol Biol Phys 95(4):1304-16, 2016. e-Pub 2016. PMID: 27354136.
301. Blanchard P, Garden AS, Gunn GB, Rosenthal DI, Morrison WH, Hernandez M, Crutison J, Lee JJ, Ye R, Fuller CD, Mohamed AS, Hutcheson KA, Holliday EB, Thaker NG, Sturgis EM, Kies MS, Zhu XR, Mohan R, Frank SJ. Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis. Radiother Oncol 120(1):48-55, 2016. e-Pub 2016. PMID: 27342249.
302. Jiang W, Mohamed AS, Fuller CD, Kim BY, Tang C, Gunn GB, Hanna EY, Frank SJ, Su SY, Diaz E, Kupferman ME, Beadle BM, Morrison WH, Skinner H, Lai SY, El-Naggar AK, DeMonte F, Rosenthal DI, Garden AS, Phan J. The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck. Pract Radiat Oncol 6(4):241-7, 2016. e-Pub 2015. PMID: 26979544.
303. Gunther JR, Liauw SL, Choi S, Mohamed AS, Thaker NG, Fuller CD, Stepaniak CJ, Das P, Golden DW. A Prostate Fossa Contouring Instructional Module: Implementation and Evaluation. J Am Coll Radiol 13(7):835-841.e1, 2016. e-Pub 2016. PMID: 27210232.
304. Mohamed AS, Rosenthal DI, Awan MJ, Garden AS, Kocak-Uzel E, Belal AM, El-Gowily AG, Phan J, Beadle BM, Gunn GB, Fuller CD. Methodology for analysis and reporting patterns of failure in the Era of IMRT: head and neck cancer applications. Radiat Oncol 11(1):95, 2016. e-Pub 2016. PMID: 27460585.
305. Wang J, Weygand J, Hwang KP, Mohamed AS, Ding Y, Fuller CD, Lai SY, Frank SJ, Zhou J. Magnetic Resonance Imaging of Glucose Uptake and Metabolism in Patients with Head and Neck Cancer. Sci Rep 6:30618, 2016. e-Pub 2016. PMID: 27461165.
306. Wong AJ, Kanwar A, Mohamed ASR, Fuller CD. Radiomics in head and neck cancer: from exploration to application. Transl Cancer Res 5(4):371-382, 2016.
307. Grossberg AJ, Chamchod S, Fuller CD, Mohamed AS, Heukelom J, Eichelberger H, Kantor ME, Hutcheson KA, Gunn GB, Garden AS, Frank S, Phan J, Beadle B, Skinner HD, Morrison WH, Rosenthal DI. Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma. JAMA Oncol 2(6):782-9, 2016. e-Pub 2016. PMID: 26891703.
308. Garden AS, Fuller CD, Rosenthal DI, William WN, Gunn GB, Beadle BM, Johnson FM, Morrison WH, Phan J, Frank SJ, Kies MS, Sturgis EM. Radiation therapy (with or without neck surgery) for phenotypic human papillomavirus-associated oropharyngeal cancer. Cancer 122(11):1702-7, 2016. e-Pub 2016. PMID: 27019396.
309. Tucker JR, Xu L, Sturgis EM, Mohamed AS, Hofstede TM, Chambers MS, Lai SY, Fuller CD, Beadle B, Gunn GB, Hutcheson KA. Osteoradionecrosis in patients with salivary gland malignancies. Oral Oncol 57:1-5, 2016. e-Pub 2016. PMID: 27208837.
310. Grossberg AJ, Mohamed AS, Fuller CD. Cachexia in Radiotherapy-Treated Patients With Head and Neck Cancer-Reply. JAMA Oncol 2(6):831-2, 2016. PMID: 27281628.
311. Holliday EB, Esmaeli B, Pinckard J, Garden AS, Rosenthal DI, Morrison WH, Kies MS, Gunn GB, Fuller CD, Phan J, Beadle BM, Zhu XR, Zhang X, Frank SJ. A Multidisciplinary Orbit-Sparing Treatment Approach That Includes Proton Therapy for Epithelial Tumors of the Orbit and Ocular Adnexa. Int J Radiat Oncol Biol Phys 95(1):344-52, 2016. e-Pub 2015. PMID: 26454680.
312. Gunn GB, Blanchard P, Garden AS, Zhu XR, Fuller CD, Mohamed AS, Morrison WH, Phan J, Beadle BM, Skinner HD, Sturgis EM, Kies MS, Hutcheson KA, Rosenthal DI, Mohan R, Gillin MT, Frank SJ. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma. Int J Radiat Oncol Biol Phys 95(1):360-7, 2016. e-Pub 2016. PMID: 27084653.
313. Wang H, Wang C, Tung S, Dimmitt AW, Wong PF, Edson MA, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Takiar V, Wang XA, Luo D, Yang JN, Wong J, Phan J. Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer. J Appl Clin Med Phys 17(3):180-189, 2016. PMID: 28297352.
314. Bishop AJ, Garden AS, Gunn GB, Rosenthal DI, Beadle BM, Fuller CD, Levy LB, Gillenwater AM, Kies MS, Esmaeli B, Frank SJ, Phan J, Morrison WH. Merkel cell carcinoma of the head and neck: Favorable outcomes with radiotherapy. Head Neck 38 Suppl 1:E452-8, 2016. e-Pub 2015. PMID: 25645649.
315. Tao R, Ma D, Takiar V, Frank SJ, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Rosenthal DI, Edson MA, Esmaeli B, Kupferman ME, Hanna EY, Garden AS, Phan J. Orbital carcinomas treated with adjuvant intensity-modulated radiation therapy. Head Neck 38 Suppl 1:E580-7, 2016. e-Pub 2015. PMID: 25782700.
316. Takiar V, Ma D, Garden AS, Li J, Rosenthal DI, Beadle BM, Frank SJ, Fuller CD, Gunn GB, Morrison WH, Hutcheson K, El-Naggar AK, Gold KA, Kupferman ME, Phan J. Disease control and toxicity outcomes for T4 carcinoma of the nasopharynx treated with intensity modulated radiotherapy. Head Neck 38 Suppl 1:E925-33, 2016. e-Pub 2015. PMID: 25994561.
317. Jiang W, Chamberlain PD, Garden AS, Kim BY, Ma D, Lo EJ, Bell D, Gunn GB, Fuller CD, Rosenthal DI, Beadle BM, Frank SJ, Morrison WH, El-Naggar AK, Glisson BS, Sturgis EM, Phan J. Prognostic value of p16 expression in Epstein-Barr virus-positive nasopharyngeal carcinomas. Head Neck 38 Suppl 1:E1459-66, 2016. e-Pub 2015. PMID: 26560893.
318. Bhattasali O, Holliday E, Kies MS, Hanna EY, Garden AS, Rosenthal DI, Morrison WH, Gunn GB, Fuller CD, Zhu XR, Frank SJ. Definitive proton radiation therapy and concurrent cisplatin for unresectable head and neck adenoid cystic carcinoma: A series of 9 cases and a critical review of the literature. Head Neck 38 Suppl 1:E1472-80, 2016. e-Pub 2015. PMID: 26561041.
319. Nien HH, Sturgis EM, Kies MS, El-Naggar AK, Morrison WH, Beadle BM, Johnson FM, Gunn GB, Fuller CD, Phan J, Gold KA, Frank SJ, Skinner H, Rosenthal DI, Garden AS, Fuller CD. Comparison of systemic therapies used concurrently with radiation for the treatment of human papillomavirus-associated oropharyngeal cancer. Head Neck 38 Suppl 1:E1554-61, 2016. e-Pub 2015. PMID: 26595157.
320. Sandulache VC, Vandelaar LJ, Skinner HD, Cata J, Hutcheson K, Fuller CD, Phan J, Siddiqui Z, Lai SY, Weber RS, Zafereo ME. Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience. Head Neck 38 Suppl 1:E1962-8, 2016. e-Pub 2016. PMID: 26879395.
321. Edson MA, Garden AS, Takiar V, Glisson BS, Fuller CD, Gunn GB, Beadle BM, Morrison WH, Frank SJ, Shah SJ, Tao R, William WN, Weber RS, Rosenthal DI, Phan J. Outcomes for hypopharyngeal carcinoma treated with organ-preservation therapy. Head Neck 38 Suppl 1:E2091-9, 2016. e-Pub 2016. PMID: 26920665.
322. Shoultz-Henley S, Garden AS, Mohamed AS, Sheu T, Kroll MH, Rosenthal DI, Gunn GB, Hayes AJ, French C, Eichelberger H, Kalpathy-Cramer J, Smith BD, Phan J, Ayoub Z, Lai SY, Pham B, Kies M, Gold KA, Sturgis E, Fuller CD. Prognostic value of pretherapy platelet elevation in oropharyngeal cancer patients treated with chemoradiation. Int J Cancer 138(5):1290-7, 2016. e-Pub 2015. PMID: 26414107.
323. Messer JA, Mohamed AS, Hutcheson KA, Ding Y, Lewin JS, Wang J, Lai SY, Frank SJ, Garden AS, Sandulache V, Eichelberger H, French CC, Colen RR, Phan J, Kalpathy-Cramer J, Hazle JD, Rosenthal DI, Gunn GB, Fuller CD. Magnetic resonance imaging of swallowing-related structures in nasopharyngeal carcinoma patients receiving IMRT: Longitudinal dose-response characterization of quantitative signal kinetics. Radiother Oncol 118(2):315-22, 2016. e-Pub 2016. PMID: 26830697.
324. MD Anderson Head and Neck Cancer Symptom Working Group. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy. Radiother Oncol 118(2):304-14, 2016. e-Pub 2016. PMID: 26897515.
325. Wang H, Wang C, Tung S, Dimmitt AW, Wong PF, Edson MA, Garden AS, Rosenthal DI, Fuller CD, Gunn GB, Takiar V, Wang XA, Luo D, Yang JN, Wong J, Phan J. Improved setup and positioning accuracy using a three-point customized cushion/mask/bite-block immobilization system for stereotactic reirradiation of head and neck cancer. J Appl Clin Med Phys 17(3):6038, 2016. e-Pub 2016. PMID: 27167275.
326. Kerkmeijer LG, Fuller CD, Verkooijen HM, Verheij M, Choudhury A, Harrington KJ, Schultz C, Sahgal A, Frank SJ, Goldwein J, Brown KJ, Minsky BD, van Vulpen M, MR-Linac Consortium Clinical Steering Committee. The MRI-Linear Accelerator Consortium: Evidence-Based Clinical Introduction of an Innovation in Radiation Oncology Connecting Researchers, Methodology, Data Collection, Quality Assurance, and Technical Development. Front Oncol 6:215, 2016. e-Pub 2016. PMID: 27790408.
327. Wang J, Narang AK, Sugar EA, Luber B, Rosati LM, Hsu CC, Fuller CD, Pawlik TM, Miller RC, Czito BG, Tuli R, Crane CH, Ben-Josef E, Thomas CR, Herman JM. Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience. Ann Surg Oncol 22 Suppl 3:1100-6, 2015. e-Pub 2015. PMID: 26224402.
328. Ding Y, Hazle JD, Mohamed AS, Frank SJ, Hobbs BP, Colen RR, Gunn GB, Wang J, Kalpathy-Cramer J, Garden AS, Lai SY, Rosenthal DI, Fuller CD. Intravoxel incoherent motion imaging kinetics during chemoradiotherapy for human papillomavirus-associated squamous cell carcinoma of the oropharynx: preliminary results from a prospective pilot study. NMR Biomed 28(12):1645-54, 2015. e-Pub 2015. PMID: 26451969.
329. Sandulache VC, Chen Y, Skinner HD, Lu T, Feng L, Court LE, Myers JN, Meyn RE, Fuller CD, Bankson JA, Lai SY. Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model. Mol Cancer Ther 14(12):2901-8, 2015. e-Pub 2015. PMID: 26376962.
330. Lai SY, Fuller CD, Bhattacharya PK, Frank SJ. Metabolic Imaging as a Biomarker of Early Radiation Response in Tumors. Clin Cancer Res 21(22):4996-8, 2015. e-Pub 2015. PMID: 26232369.
331. Holliday EB, Fuller CD, Kalpathy Cramer J, Gomez D, Rimner A, Li Y, Senan S, Wilson LD, Choi J, Komaki R, Thomas CR. Quantitative assessment of target delineation variability for thymic cancers: agreement evaluation of a prospective segmentation challenge. J Radiat Oncol, 2015. e-Pub 2017. PMID: 27570583.
332. Sturgeon JD, Cox JA, Mayo LL, Gunn GB, Zhang L, Balter PA, Dong L, Awan M, Kocak-Uzel E, Mohamed AS, Rosenthal DI, Fuller CD. Improved human observer performance in digital reconstructed radiograph verification in head and neck cancer radiotherapy. Int J Comput Assist Radiol Surg 10(10):1667-73, 2015. e-Pub 2014. PMID: 25477277.
333. Gunn GB, Hansen CC, Garden AS, Fuller CD, Mohamed AS, Morrison WH, Frank SJ, Beadle BM, Phan J, Chronowski GM, Sturgis EM, Lewis CM, Lu C, Hutcheson KA, Mendoza TR, Cleeland CS, Rosenthal DI. Favorable patient reported outcomes following IMRT for early carcinomas of the tonsillar fossa: Results from a symptom assessment study. Radiother Oncol 117(1):132-8, 2015. e-Pub 2015. PMID: 26403258.
334. Roy A, Fuller CD, Rosenthal DI, Thomas CR. Comparison of measurement methods with a mixed effects procedure accounting for replicated evaluations (COM3PARE): method comparison algorithm implementation for head and neck IGRT positional verification. BMC Med Imaging 15:35, 2015. e-Pub 2015. PMID: 26310853.
335. Ding Y, Mohamed AS, Yang J, Colen RR, Frank SJ, Wang J, Wassal EY, Wang W, Kantor ME, Balter PA, Rosenthal DI, Lai SY, Hazle JD, Fuller CD. Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications?. Pract Radiat Oncol 5(4):e299-308, 2015. e-Pub 2014. PMID: 25544553.
336. Holliday EB, Ahmed AA, Jagsi R, Stentz NC, Woodward WA, Fuller CD, Thomas CR. Pregnancy and Parenthood in Radiation Oncology, Views and Experiences Survey (PROVES): Results of a Blinded Prospective Trainee Parenting and Career Development Assessment. Int J Radiat Oncol Biol Phys 92(3):516-24, 2015. e-Pub 2015. PMID: 25892584.
337. Rosenthal DI, Fuller CD, Peters LJ, Thames HD. Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses. Int J Radiat Oncol Biol Phys 92(4):715-7, 2015. PMID: 26104925.
338. Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS, Morrison WH, Lewin JS, El-Naggar AK, Ginsberg LE, Kocak-Uzel E, Ang KK, Fuller CD. Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: A 3-decade survey. Cancer 121(10):1608-19, 2015. e-Pub 2015. PMID: 25586197.
339. Awan M, Dyer BA, Kalpathy-Cramer J, Bongers E, Dahele M, Yang J, Walker GV, Thaker NG, Holliday E, Bishop AJ, Thomas CR, Rosenthal DI, Fuller CD. Auto-segmentation of the brachial plexus assessed with TaCTICS - A software platform for rapid multiple-metric quantitative evaluation of contours. Acta Oncol 54(4):1-5, 2015. e-Pub 2014. PMID: 25279958.
340. Mohamed AS, Ruangskul MN, Awan MJ, Baron CA, Kalpathy-Cramer J, Castillo R, Castillo E, Guerrero TM, Kocak-Uzel E, Yang J, Court LE, Kantor ME, Gunn GB, Colen RR, Frank SJ, Garden AS, Rosenthal DI, Fuller CD. Quality Assurance Assessment of Diagnostic and Radiation Therapy-Simulation CT Image Registration for Head and Neck Radiation Therapy: Anatomic Region of Interest-based Comparison of Rigid and Deformable Algorithms. Radiology 274(3):132871, 2015. e-Pub 2014. PMID: 25380454.
341. Tang C, Fuller CD, Garden AS, Awan MJ, Colen RR, Morrison WH, Frank SJ, Beadle BM, Phan J, Sturgis EM, Zafereo ME, Weber RS, Rosenthal DI, Gunn GB. Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: Quantitative image analysis of post-radiotherapy response. Oral Oncol 51(2):195-201, 2015. e-Pub 2014. PMID: 25444304.
342. Baron CA, Awan MJ, Mohamed AS, Akel I, Rosenthal DI, Gunn GB, Garden AS, Dyer BA, Court L, Sevak PR, Kocak-Uzel E, Fuller CD. Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on-rails imaging. J Appl Clin Med Phys 16(1):159-169, 2015. PMID: 28297253.
343. Garden AS, Gunn GB, Hessel A, Beadle BM, Ahmed S, El-Naggar AK, Fuller CD, Byers LA, Phan J, Frank SJ, Morrison WH, Kies MS, Rosenthal DI, Sturgis EM. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer. Cancer 120(19):3082-8, 2014. e-Pub 2014. PMID: 24898672.
344. Sheu T, Fuller CD, Mendoza TR, Garden AS, Morrison WH, Beadle BM, Phan J, Frank SJ, Hanna EY, Lu C, Cleeland CS, Rosenthal DI, Gunn GB. Nomogram for Predicting Symptom Severity during Radiation Therapy for Head and Neck Cancer. Otolaryngol Head Neck Surg 151(4):619-26, 2014. e-Pub 2014. PMID: 25104816.
345. Mavroidis P, Giantsoudis D, Awan MJ, Nijkamp J, Rasch CR, Duppen JC, Thomas CR, Okunieff P, Jones WE, Kachnic LA, Papanikolaou N, Fuller CD, Southwest Oncology Group Radiation Oncology Committee. Consequences of anorectal cancer atlas implementation in the cooperative group setting: Radiobiologic analysis of a prospective randomized in silico target delineation study. Radiother Oncol 112(3):418-24, 2014. e-Pub 2014. PMID: 24996454.
346. Walker GV, Awan M, Tao R, Koay EJ, Boehling NS, Grant JD, Sittig DF, Gunn GB, Garden AS, Phan J, Morrison WH, Rosenthal DI, Mohamed AS, Fuller CD. Prospective randomized double-blind study of atlas-based organ-at-risk autosegmentation-assisted radiation planning in head and neck cancer. Radiother Oncol 112(3):321-5, 2014. e-Pub 2014. PMID: 25216572.
347. Awan MJ, Mohamed AS, Lewin JS, Baron CA, Gunn GB, Rosenthal DI, Holsinger FC, Schwartz DL, Fuller CD, Hutcheson KA. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: A preliminary dosimetric comparison. Oral Oncol 50(8):746-52, 2014. e-Pub 2014. PMID: 24906528.
348. Rosenthal DI, Mendoza TR, Fuller CD, Hutcheson KA, Wang XS, Hanna EY, Lu C, Garden AS, Morrison WH, Cleeland CS, Gunn GB. Patterns of symptom burden during radiotherapy or concurrent chemoradiotherapy for head and neck cancer: A prospective analysis using the University of Texas MD Anderson Cancer Center Symptom Inventory-Head and Neck Module. Cancer 120(13):1975-84, 2014. e-Pub 2014. PMID: 24711162.
349. Kocak-Uzel E, Gunn GB, Colen RR, Kantor ME, Mohamed AS, Schoultz-Henley S, Mavroidis P, Frank SJ, Garden AS, Beadle BM, Morrison WH, Phan J, Rosenthal DI, Fuller CD. Beam path toxicity in candidate organs-at-risk: Assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy. Radiother Oncol 111(2):281-8, 2014. e-Pub 2014. PMID: 24746582.
350. Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Fuller CD. Gender differences in publication productivity, academic position, career duration, and funding among U.S. academic radiation oncology faculty. Acad Med 89(5):767-73, 2014. PMID: 24667510.
351. Choi M, Holliday EB, Jagsi R, Wilson LD, Fuller CD, Thomas CR. Citation-based Estimation of Scholarly Activity Among Domestic Academic Radiation Oncologists: Five-Year Update. J Radiat Oncol 3(1):115-122, 2014. PMID: 24678385.
352. Kalpathy-Cramer J, Awan M, Bedrick S, Rasch CR, Rosenthal DI, Fuller CD. Development of a Software for Quantitative Evaluation Radiotherapy Target and Organ-at-Risk Segmentation Comparison. J Digit Imaging 27(1):108-19, 2014. e-Pub 2013. PMID: 24043593.
353. Holliday EB, Jagsi R, Thomas CR, Wilson LD, Fuller CD. Standing on the Shoulders of Giants: Results From the Radiation Oncology Academic Development and Mentorship Assessment Project (ROADMAP). Int J Radiat Oncol Biol Phys 88(1):18-24, 2014. e-Pub 2013. PMID: 24210670.
354. Baron CA, Awan MJ, Mohamed AS, Akel I, Rosenthal DI, Gunn GB, Garden AS, Dyer BA, Court L, Sevak PR, Kocak-Uzel E, Fuller CD. Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imaging. J Appl Clin Med Phys 16(1):5108, 2014. e-Pub 2014. PMID: 25679151.
355. Gunn GB, Mendoza TR, Fuller CD, Gning I, Frank SJ, Beadle BM, Hanna EY, Lu C, Cleeland CS, Rosenthal DI. High Symptom Burden Prior to Radiation Therapy for Head and Neck Cancer: A Patient-Reported Outcomes Study. Head Neck 35(10):1490-8, 2013. e-Pub 2012. PMID: 23169304.
356. Gunn GB, Debnam JM, Fuller CD, Morrison WH, Frank SJ, Beadle BM, Sturgis EM, Glisson BS, Phan J, Rosenthal DI, Garden AS. The impact of radiographic retropharyngeal adenopathy in oropharyngeal cancer. Cancer 119(17):3162-9, 2013. e-Pub 2013. PMID: 23733178.
357. Rana S, Holliday EB, Jagsi R, Wilson LD, Choi M, Thomas CR, Fuller CD. Scholastic activity among radiation oncology residents at US academic institutions: a benchmark analysis. J Cancer Educ 28(3):541-6, 2013. PMID: 23828146.
358. Awan M, Kalpathy-Cramer J, Gunn GB, Beadle BM, Garden AS, Phan J, Holliday E, Jones WE, Maani E, Patel A, Choi J, Clyburn V, Tantiwongkosi B, Rosenthal DI, Fuller CD. Prospective Assessment of an Atlas-Based Intervention Combined With Real-Time Software Feedback in Contouring Lymph Node Levels and Organs-at-Risk in the Head and Neck: Quantitative Assessment of Conformance to Expert Delineation. Pract Radiat Oncol 3(3):186193, 2013. PMID: 23853674.
359. Awan M, Kalpathy-Cramer J, Gunn GB, Beadle BM, Garden AS, Phan J, Holliday E, Jones WE, Maani E, Patel A, Choi J, Clyburn V, Tantiwongkosi B, Rosenthal DI, Fuller CD. Prospective assessment of an atlas-based intervention combined with real-time software feedback in contouring lymph node levels and organs-at-risk in the head and neck: Quantitative assessment of conformance to expert delineation. Pract Radiat Oncol 3(3):186-93, 2013. e-Pub 2012. PMID: 24674363.
360. Ramahi E, Choi J, Fuller CD, Eng TY. Merkel cell carcinoma. Am J Clin Oncol 36(3):299-309, 2013. PMID: 21422993.
361. Holliday E, Fuller CD, Wilson LD, Thomas CR. Success Breeds Success: Authorship Distribution in the Red Journal 1975-2011. Int J Radiat Oncol Biol Phys 85(1):23-8, 2013. e-Pub 2012. PMID: 22560553.
362. Quigley MR, Holliday EB, Fuller CD, Choi M, Thomas CR. Distribution of the h-Index in Radiation Oncology Conforms to a Variation of Power Law: Implications for Assessing Academic Productivity. J Cancer Educ. e-Pub 2012. PMID: 22544537.
363. Fuller CD. Human-Computer Interaction in Radiotherapy Target Volume Delineation: A Prospective, Multi-institutional Comparison of User Input Devices. Journal of Digital Imaging 24(5):794-803, 2011. PMID: 20978922.
364. Mendoza TR, Gunn GB, Fuller CD, Wang XS, Rosenthal DI, Cleeland CS. The utility of using area under the curve to analyze symptom burden during radiation/chemoradiation for head and neck cancer. J Clin Oncol 29(15_suppl):5525, 2011. PMID: 28021394.
365. Fuller CD, Nijkamp J, Duppen J, Rasch CRN, Thomas CR, Wang SJ, Okunieff P, Jones WE, Baseman DB, Patel S, Demandante CGN, Harris AM, Smith BD, Katz AW, McGann C, Harper JL, Chang DT, Smalley S, Marshall DT, Goodman KA, Papanikolaou N, Kachnic LA. Prospective randomized double-blind pilot study of site-specific consensus atlas implementation for rectal cancer target volume delineation in the cooperative group setting,. Int J Radiat Oncol Biol Phys 79(2):481-9, 2011.
366. Jung AJ, Hardeman RL, Peng Q, Fuller CD, El-Merhi F, Dalrymple NC, Jung A. Prospective Multiparametric 3.0T Endorectal Prostate MRI Imaging Observations in Low-Grade Prostate Cancer. Cancer Investigations, 2011.
367. Baluna R, Fuller CD, Eng TY, Thomas CR. Radiation-induced toxicity in cancer patients with low plasma fibronectin levels. Journal of Radiotherapy in Practice, 2011.
368. Mesa F, Eng TY, Esquivel C, Fuller CD, Papanikolaou N, Sosa M. Implementation of a lateral total body irradiation technique with 6 MV photons. Journal of Radiotherapy in Practice, 2011.
369. Wang SJ, Wissel AR, Luh JY, Fuller CD, Kalpathy-Cramer J, Thomas CR. An Interactive Tool for Individualized Estimation of Conditional Survival in Rectal Cancer. Annals of Surgical Oncology, 2011.
370. Wang SJ, Wissel AR, Luh JY, Fuller CD, Kalpathy-Cramer J, Thomas CR. Individualized Estimation of Conditional Survival for Patients with Head and Neck Cancer. Annals of Surgical Oncology, 2011.
371. Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord C, Walker G, Fuller CD, Kim JS, Thomas CR. A Nomogram for Predicting the Benefit of Adjuvant Chemoradiotherapy for Resected Gallbladder Cancer. Journal of Clinical Oncology, 2011.
372. Ciura K, McBurney M, Nguyen B, Pham M, Rebueno N, Fuller CD, Guha-Thakurta N, Rosenthal DI. Effect of Brain Stem and Dorsal Vagus Complex Dosimetry on Nausea and Vomiting in Head and Neck Intensity Modulated Radiation Therapy. Med Dosim 36(1):41-5, 2011. e-Pub 2010. PMID: 20097059.
373. Kalpathy-Cramer J, Bedrick SD, Boccia K, Fuller CD. A pilot prospective feasibility study of organ-at-risk definition using Target Contour Testing/Instructional Computer Software (TaCTICS), a training and evaluation platform for radiotherapy target delineation. AMIA Annu Symp Proc 2011:654-63, 2011. e-Pub 2011. PMID: 22195121.
374. Rosenthal DI, Fuller CD, Barker JL, Mason B, Garcia JA, Lewin J, Holsinger FC, Stasney R, Frank SJ, Schwartz DL, Morrison WH, Garden AS, Ang KK. Simple Carotid-Sparing IMRT Technique and Preliminary Experience for T1-2 Glottic Cancer. Int J Radiat Oncol Biol Phys 77(2):455-61, 2010. PMID: 19679406.
375. Zamboni BA, Yothers G, Choi M, Fuller CD, Dignam JJ, Raich PC, Thomas CR, O'Connell MJ, Wolmark N, Wang SJ. Conditional Survival and the Choice of Conditioning Set for Patients with Colon Cancer: An Analysis of NSABP Trials C-03 through C-07. Journal of Clinical Oncology 28(15):2544-8, 2010. PMID: 20406942.
376. Fuller CD, Ramahi EH, Aherne N, Eng TY, Giaccone G, Thomas CR. Radiotherapy for Thymic Neoplasms. Journal of Thoracic Oncology(5):S327-335, 2010.
377. Fuller CD, Thomas CR. Chemoradiation for Anal Cancer: The More Things Change, the More They Stay the Same. Oncology (Williston Park) 24(5):427-30, 2010.
378. Kalpathy-Cramer J, Fuller CD. Target Contour Testing/Instructional Computer Software (TaCTICS): A Novel Training and Evaluation Platform for Radiotherapy Target Delineation. American Informatics Association Annual Symposium Proceedings:361-365, 2010.
379. Wang SJ, Kalpathy-Cramer J, Kim JS, Fuller CD, Thomas CR. Parametric Survival Models for Predicting the Benefit of Adjuvant Chemoradiotherapy in Gallbladder Cancer. American Informatics Association Annual Symposium Proceedings:847-851, 2010.
380. Fuller CD, Scarbrough TJ, Sonke JJ, Rasch CRN, Choi M, Ting JY, Wang S, Papanikolaou N, Rosenthal DI. Method comparison of automated matching software assisted cone-beam CT and stereoscopic kilovoltage X-ray positional verification image-guided radiation therapy for head and neck cancer: a prospective analysis,. Physics in Medicine and Biology 54(24):7401-15, 2009. PMID: 19934488.
381. Fuller CD, Dang ND, Wang SJ, Desai P, Choi M, Thomas CR, Fuss M. Image-guided intensity-modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas: Initial clinical results. Radiother Oncol 92(2):249-54, 2009. e-Pub 2009. PMID: 19324442.
382. Choi M, Fuller CD, Thomas CR. Estimation of citation-based scholarly activity among radiation oncology faculty at domestic residency-training institutions: 1996-2007. Int J Radiat Oncol Biol Phys 74(1):172-8, 2009. e-Pub 2008. PMID: 18990506.
383. Choi M, Fuller CD, Wang SJ, Siddiqi A, Wong A, Thomas CR, Fuss M. Effect of body mass index on shifts in ultrasound-based image-guided intensity-modulated radiation therapy for abdominal malignancies. Radiother Oncol 91(1):114-9, 2009. e-Pub 2008. PMID: 18804301.
384. Fuller CD, Choi M, Thomas CR. Bibliometric analysis of radiation oncology departmental scholarly publication productivity at domestic residency training institutions. J Am Coll Radiol 6(2):112-8, 2009. PMID: 19179240.
385. Fuller CD, Wang SJ, Choi M, Czito BG, Cornell J, Welzel T, McGlynn K, Luh J, Thomas CR. Multimodality therapy for locoregional extrahepatic cholangiocarcinoma: a population based analysis. Cancer 27(115):5175-5183, 2009.
386. Bleyer A, Choi M, Fuller CD, Thomas CR Jr, Wang SJ. Relative Lack of Conditional Survival Improvement in Adolescents and Young Adults with Cancer. Seminars in Oncology 36(5):460-467, 2009.
387. Okunieff P, Kachnic LA, Constine LS, Fuller CD, Gaspar LE, Hayes DF, Hooks J, Ling C, Meyskens FL, Phillip PA, Raben D, Smalley SR, Swanson GP, Teicher B, Thomas CR, Vikram B, Zelefsky MJ, Baker LH. Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG):Research Objectives Workshop 2008. Clinical Cancer Research 15(18):5663-70, 2009.
388. Fuller CD, Dang N, Wang SJ, Desai P, Choi M, Thomas CR, Fuss M. Image-guided intensity modulated radiotherapy (IG-IMRT) for biliary adenocarcinomas:initial clinical results, Radiotherapy and oncology. journal of the European Society for Therapeutic Radiology and Oncology 92(2):249-54, 2009.
389. Fuller CD, Choi M, Thomas CR. Bibliometric analysis of radiation oncology departmental scholarly publication productivity at domestic residency-training institutions:1996-2007. Journal of the American College of Radiology 6(2):112-8, 2009.
390. Rosenthal DI, Chambers MS, Fuller CD, Rebueno NC, Garcia J, Kies MS, Morrison WH, Ang KK, Garden AS. Beam Path Toxicities to Non-Target Structures during Intensity-Modulated Radiation Therapy for Head and Neck Cancers. Int J Radiat Oncol Biol Phys 72(3):747-755, 2008. e-Pub 2008. PMID: 18455324.
391. Fuller CD, Schillerstrom JE, Jones WE, Boersma M, Royall DR, Fuss M. Prospective Evaluation of Pretreatment Executive Cognitive Impairment and Depression in Patients Referred for Radiotherapy. Int J Radiat Oncol Biol Phys 72(2):529-533, 2008. e-Pub 2008. PMID: 18411001.
392. Fuller CD, Housman DM, Thomas CR. Radiotherapy for Thymoma and Thymic Carcinoma. Hematol Oncol Clin North Am 22(3):489-507, 2008. PMID: 18514129.
393. Choi M, Fuller CD, Thomas CR, Wang SJ. Conditional survival in ovarian cancer: results from the SEER dataset 1988-2001. Gynecol Oncol 109(2):203-9, 2008. e-Pub 2008. PMID: 18329082.
394. Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR, Ravdin PM. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol 26(13):2112-7, 2008. e-Pub 2008. PMID: 18378567.
395. Wang SJ, Fuller CD, Choi M, Thomas CR. A cost-effectiveness analysis of adjuvant chemoradiotherapy for resected gastric cancer. Gastrointest Cancer Res 2(2):57-63, 2008. PMID: 19259297.
396. Bleyer A, Choi M, Wang SJ, Fuller CD, Raney RB, Thomas CR. Increased vulnerability of the spinal cord to radiation and intrathecal chemotherapy during adolescence: A report from the Children's Oncology Group,. Pediatric Blood & Cancer 53(7):1205-1210, 2008. PMID: 19821538.
397. Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR, Ravdin P. A Prediction Model for Estimating the Survival Benefit of Adjuvant Radiotherapy. Am J Clin Oncol 26(13):2112-7, 2008.
398. Wang SJ, Fuller CD, Choi M, Thomas CR. A Cost-Effectiveness Analysis of Adjuvant Chemoradiation Therapy for Gastric Cancer. Gastrointestinal Cancer Research 2(2):57-63, 2008.
399. Choi M, Fuller CD, Siddiqi A, Wong A, Thomas CR, Fuss M. Effects of Body Mass Index on Shifts in Ultrasound-Based Image-Guided Intensity-Modulated Radiation Therapy for Abdominal Malignancies. Radiat Oncol 91(1):114-9, 2008.
400. Eng TY, Boersma MG, Fuller CD, Goytia V, Jones WE, Joyner M, Nguyen DD. A comprehensive review of the treatment of Merkel cell carcinoma. Am J Clin Oncol 30(6):624-36, 2007. PMID: 18091058.
401. Wang SJ, Choi M, Fuller CD, Salter BJ, Fuss M. Intensity-modulated Radiosurgery for patients with brain metastases: a mature outcomes analysis. Technol Cancer Res Treat 6(3):161-8, 2007. PMID: 17535023.
402. Wang SJ, Fuller CD, Emery R, Thomas CR. Conditional Survival in Rectal Cancer: A SEER Database Analysis. Gastrointest Cancer Res 1(1):84, 2007. PMID: 19262713.
403. Fuller CD, Wang SJ, Thomas CR, Hoffman HT, Weber RS, Rosenthal DI. Conditional survival in head and neck squamous cell carcinoma: results from the SEER dataset 1973-1998. Cancer 109(7):1331-43, 2007. PMID: 17326199.
404. Wang SJ, Fuller CD, Thomas CR. Ethnic disparities in conditional survival of patients with non-small cell lung cancer. J Thorac Oncol 2(5):180-90, 2007. PMID: 17410040.
405. Wang SJ, Emery R, Fuller CD, Kim JS, Sittig DF, Thomas CR. Conditional survival in gastric cancer: a SEER database analysis. Gastric Cancer 10(3):153-8, 2007. e-Pub 2007. PMID: 17922092.
406. Fuss M, Wong A, Fuller CD, Salter BJ, Fuss C, Thomas CR. Image-guided intensity-modulated radiotherapy for pancreatic carcinoma. Gastrointest Cancer Res 1(1):2-11, 2007. PMID: 19262697.
407. Marks L, Fuller CD, Sangvi P, Pinn M, Thomas CR Jr. Update on the Rheumatologic Manifestations of Malignancy. Current Cancer Therapy Reviews 3(3):215-222, 2007.
408. Fuller CD, Choi M, Forthuber B, Wang SJ, Rajagiriyil N, Salter BJ, Fuss M. Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme. Radiat Oncol 14(2):26, 2007. e-Pub 2007. PMID: 17629934.
409. Lai LL, Fuller CD, Kachnic LA, Thomas CR. Can pelvic radiotherapy be omitted in select patients with rectal cancer?. Semin Oncol 33(6 Suppl 11):S70-4, 2006. PMID: 17178292.
410. Fuller CD, Thomas CR, Wong A, Cavanaugh SX, Salter BJ, Herman TS, Fuss M. Image-guided intensity-modulated radiation therapy for gallbladder carcinoma. Radiother Oncol 81(1):65-72, 2006. e-Pub 2006. PMID: 16971012.
411. Fuller CD, Thomas CR, Schwartz S, Golden N, Ting J, Wong A, Erdogmus D, Scarbrough TJ. Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting. Phys Med Biol 51(19):4981-93, 2006. e-Pub 2006. PMID: 16985282.
412. Scarbrough TJ, Golden NM, Ting JY, Fuller CD, Wong A, Kupelian PA, Thomas CR. Comparison of ultrasound and implanted seed marker prostate localization methods: Implications for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 65(2):378-87, 2006. e-Pub 2006. PMID: 16563658.
413. Eng TY, Boersma MK, Fuller CD, Luh JY, Siddiqi A, Wang S, Thomas CR. The role of radiation therapy in benign diseases. Hematol Oncol Clin North Am 20(2):523-57, 2006. PMID: 16730305.
414. Rassiah-Szegedi P, Salter BJ, Fuller CD, Blough M, Papanikolaou N, Fuss M. Monte Carlo characterization of target doses in stereotactic body radiation therapy (SBRT). Acta Oncol 45(7):989-94, 2006. PMID: 16982568.
415. Rosenthal DI, Fuller CD, Machtay M, Algazy KM, Meyer DM, Kaiser LR, Yardley DA, Loiacano ME, Carbone DP. Phase I study of Paclitaxel given by seven-week continuous infusion concurrent with radiation therapy for locally advanced non-small cell lung cancer. J Thorac Oncol 1(1):38-45, 2006. PMID: 17409825.
416. Jones K, Fuller CD, Luh JY, Childs CC, Miller AR, Tolcher AW, Herman TS, Thomas CR. Case report and summary of literature: giant perineal keloids treated with post-excisional radiotherapy. BMC Dermatol 6:7, 2006. e-Pub 2006. PMID: 16623939.
417. Esquivel C, Fuller CD, Waggener RG, Wong A, Meltz M, Blough M, Eng TY, Thomas CR. Novel low-kVp beamlet system for choroidal melanoma. Radiat Oncol 1:36, 2006. e-Pub 2006. PMID: 16965624.
418. Fuller CD, Thomas CR, Voeltz L, Salter BJ, Fuss M. Thermo-luminescent dosimeter evaluation of extra-target dose in intensity modulated sequential tomotherapy for pancreatic cancer. Journal of Radiotherapy in Practice 5(3):173-176, 2006.
419. Luh JY, Eng TY, Fuller CD. Minimizing urinary bladder radiation dose during brachytherapy for carcinoma of the cervix using balloon inflation technique: In regard to Malaker et al. (Int J Radiat Oncol Biol Phys 2005;61:257-266). Int J Radiat Oncol Biol Phys 62(3):944; author reply 944-5, 2005. PMID: 15936589.
420. Garcia JA, Bhakta S, Fuller CD, Thomas CR. Multidisciplinary approach to superior sulcus tumors. Cancer J 11(3):189-97, 2005. PMID: 16053660.
421. Koshy MC, Landry JC, Cavanaugh SX, Fuller CD Willett CG, Abrams RA, Hoffman JP, Thomas CR. A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys 61(4):965-6, 2005. PMID: 15752874.
422. Cavanaugh SX, Fuller CD, Kupelian PA, Reddy C, Bradshaw P, Pollock BH, Fuss M. Time and PSA threshold model prognosticates long-term overall and disease-specific survival in prostate cancer patients as early as 3 months after external beam radiation therapy. Prostate Cancer Prostatic Dis 8(4):353-8, 2005. PMID: 16158079.
423. Eng TY, Naguib M, Fuller CD, Jones WE, Herman TS. Treatment of recurrent Merkel cell carcinoma: an analysis of 46 cases. Am J Clin Oncol 27(6):576-83, 2004. PMID: 15577435.
424. Eng TY, Boersma MG, Fuller CD, Cavanaugh SX, Valenzuela F, Herman TS. Treatment of merkel cell carcinoma. Am J Clin Oncol 27(5):510-5, 2004. PMID: 15596922.
425. Fuller CD, Diaz I, Cavanaugh SX, Eng TY. In vivo dose perturbation effects of metallic dental alloys during head and neck irradiation with intensity modulated radiation therapy. Oral Oncol 40(6):645-8, 2004. PMID: 15063394.
426. Eng TY, Fuller CD, Jagirdar J, Bains Y, Thomas CR. Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59(3):654-64, 2004. PMID: 15183468.
427. Cavanaugh SX, Kupelian PA, Fuller CD, Reddy C, Bradshaw P, Pollock BH, Fuss M. Early prostate-specific antigen (PSA) kinetics following prostate carcinoma radiotherapy: prognostic value of a time-and-PSA threshold model. Cancer 101(1):96-105, 2004. PMID: 15221994.
428. Fuss M, Salter BJ, Cavanaugh SX, Fuss C, Sadeghi A, Fuller CD, Ameduri A, Hevezi JM, Herman TS, Thomas CR. Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies. Int J Radiat Oncol Biol Phys 59(4):1245-56, 2004. PMID: 15234062.
429. Eng TY, Fuller CD, Cavanaugh SX, Blough MM, Sadeghi A, Herman T. Significant rectal and bladder dose reduction via utilization of Foley balloon catheters in high-dose-rate tandem and ovoid intracavitary brachytherapy of the uterine cervix. Int J Radiat Oncol Biol Phys 59(1):174-8, 2004. PMID: 15093914.
430. Eng TY, Naguib M, Galang T, Fuller CD. Retrospective study of the treatment of urethral cancer. Am J Clin Oncol 26(6):558-62, 2003.
431. Hamilton ML, Guo Z, Fuller CD, Van Remmen H, Ward WF, Austad SN, Troyer DA, Thompson I, Richardson A. A reliable assessment of 8-oxo-2-deoxyguanosine levels in nuclear and mitochondrial DNA using the sodium iodide method to isolate DNA. Nucleic Acids Res 29(10):2117-26, 2001. PMID: 11353081.

Invited Articles

1. Fuller CD. Multidisciplinary management of head and neck cancer. Head & Neck.

Manuals, Teaching Aids, Other Teaching Publications

1. Fuller CD. Target Contour Testing/Instructional Computer Software (TaCTICS): A Novel Training and Evaluation Platform for Radiotherapy Target Delineation http://skynet.ohsu.edu/tactics/, 2005.

Editorials

1. Fuller CD, Nijkamp J, Rasch CRN, Duppen J, Kachnic L, Okunieff P, Marshall D, Katz AW, Smith BD, Thomas CR. Impact of rectal cancer target volume consensus atlas implementation in the cooperative group setting: Preliminary results from a prospective randomized double-blind pilot study, 2010 Gastrointestinal Cancers Symposium. ASCO, 2010.
2. Lai LL, Fuller CD, Kachnic LA, Thomas CR. Can pelvic radiotherapy be omitted in select patients with rectal cancer?. Seminars in oncology 33(6 Suppl 11):S70-4, 2006.
3. Koshy MC, Landry JC, Cavanaugh SX, Fuller CD, Willett CG, Abrams RA, Hoffman JP, Thomas CR Jr. A challenge to the therapeutic nihilism of ESPAC-1. International Journal of Radiation Oncology, Biology, Physics 61(4):965-6, 2005.
4. Fuller CD, Braden CJ, Thomas CR Jr. Quality of life: from a Tower of Babel toward a unified voice. International Journal of Radiation Oncology*Biology*Physics 58(5):1334-5, 2004.

Abstracts

1. Sandulache VC, Chen Y, Feng L, William WN, Skinner HD, Myers JN, Meyn RE, Li J, Mijiti A, Bankson JA, Fuller CD, Konopleva MY, Lai SY. Metabolic interrogation as a tool to optimize chemotherapeutic. Oncotarget, Advance Publications 2017, 2017. PMID: 28184025.
2. Cardenas C, Wong A, Mohamed A, Yang J, Court L, Rao A, Fuller CD, Aristophanous M. SU-C-BRA-05: Delineating high-dose clinical target volumbes for head and neck tumors using machine learning algorithms. Medical Physics, 2016.
3. Ger R, Awan M, Mohamed A, Ding Y, Frank SJ, Howell R, Li H, Liu H, Mohan R, Schellingerhout D, Stafford R, Wang J, Fuller CD, Court L. WE-FG-202-12: Investigation of longitudinal salivary gland DCE-MRI changes. Medical Physics, 2016.
4. Ding Y, Mohamed A, Ma J, Frank SJ, Wang J, Fuller CD. SU-G-IeP1-05: Diffusion kurtosis imaging for oropharyngeal cancer detection, 2016.
5. Ho JC, Allen PK, Bhosale P, Rauch GM, Fuller CD, Mohamed A, Frumovitz M, Jhingran A, Eifel P, Klopp AH. Functional imaging predictors of outcome in cervical cancer following chemoradiation, 2016.
6. Phan J, Brown P, Nandita GT, Rosenthal D, Garden A, Gunn GB, Fuller CD, Li J, Ghia A, Yang J, Luo D, Su S, Hanna E, DeMonte F. Gamma knife stereotactic radiosurgery for trigeminal neuralgia secondary to recurrent skull base malignancies, 2016.
7. Goepfert RP, Lewin JS, Barrow MP, Gunn GB, Fuller CD, Beadle BM, Garden AS, Rosenthal DI, Kies MS, Papadimitrakopoulou S, Lai S, Schwartz DL, Hutcheson KA. Prospective MD Anderson dysphagia inventory outcomes after nonsurgical treatment of locoregionally advanced oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 2016.
8. Hansen CC, Chrane K, Gunn GB, Mohamed ASR, Rosenthal DI, Wefel JS, Phan J, Frank SJ, Garden AS, Smith B, Eichelberger H, Anderson C, McCoy C, Horiates M, Patrick C, Floris S, French C, Beadle BM, Morrison WH, Su SY, Hanna EY, Lewis CM, Skinner HD, Lai S, Fuller CD. Cognitive function and patient-reported memory problem following radiation therapy for cancers at the skull base: A survivorship study using the telephone interview for gognitive status and the MDASI-HN. Int J Radiat Oncol Biol Phys, 2016.
9. Hutcheson KA, Lin H, Yuk MM, Hubbard RM, Barrow MP, Gunn GB, Fuller CD, Garden AS, Lai S, Schwartz DL, Kies MS, Hanna EY, Goepfert RP, Lewin JS. Lower cranial neuropathy after oropharyngeal intensity modulated radiation therapy (IMRT): A prospective study and literature review. Int J Radiat Oncol Biol Phys, 2016.
10. Mohamed ASR, Shoultz Henley S, Garden AS, Sheu T, Kroll M, Rosenthal DI, Gunn GB, Phan J, Lai S, Kies MS, Gold KA, Sturgis EM, Fuller CD. Pretreatment complete blood count improves prognostic model survival prediction in oropharynageal cancer patients trwated with radiation therapy. Int J Radiat Oncol Biol Phys 94(4):964, 2016.

Book Chapters

1. Zindler J, Fuller CD, Thomas CR Jr. Assessment of Radiotherapeutic Strategies in Phase I Trials. In: Phase I Trials in Oncology. Springer, 2019.
2. Elhalawani H, Rao A, Fuller CD. The essence of R in head and neck cancer:Role of radiomics and radiogenomics from a radiation oncology perspective. In: Radiomics and Radiogenomics: Technical Basis and Clinical Applications, 1st Edition. Chapman and Hall/CRC: New York, pp. 265-281, 2019.
3. Holliday EB, Smith BD. Gross NP, Fuller CD, Rosenthal DI. Larynx Cancer. In: The American Cancer Society's Oncology in Practice: Clinical Management. The American Cancer Society: USA, 2018.
4. Holliday EB, Kupferman M, Fuller CD, Hanna E. Nasal and Paranasal Sinus Cancer. In: The American Cancer Society's Oncology in Practice: Clinical Management. The American Cancer Society: USA, 2018.
5. Pawlowski JM, Holliday EB, Fuller CD. Nasopharynx Cancer. In: The American Cancer Society's Oncology in Practice: Clinical Management. The American Cancer Society: USA, 2018.
6. Berman AT, Fuller CD, Gillespie E, Chen Y, Thomas CR Jr. Methodology in Clinical Trials. In: Practice and Principles of Radiation Oncology, 7th edition. Lippincott Williams Wilkins: Philadelphia, 2018.
7. Shervani S, Gomez D, Fuller CD, Thomas CR Jr. Mediastinal & Tracheal Cancers. In: Practice and Principles of Radiation Oncology, 7th edition. Lippincott Williams Wilkins: Philadelphia, 2018.
8. Gomez D, Chennupati S, Fuller CD, Thomas CR Jr. Mediastinal & Tracheal Cancers. In: Practice and Principles of Radiation Oncology, 6th edition. Lippincott Williams Wilkins: Philadelphia, pp. 973-997, 2013.
9. Fuller CD, Diehl AK. In: Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, 2008.
10. Czito B, Willett C, Fuller CD. In: Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, 2008.
11. Fuller CD, Thomas, CR. In: Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, Demos Medical Publishing, 2008.
12. Hung AY, Eng TY, Scarbrough TJ, Fuller CD, Thomas CR. In: Perez and Brady's Principles and Practice of Radiation Oncology, Fifth Edition, Lippincott Williams & Wilkins, 2007.
13. Eng TY, Boersma MGK, Fuller CD. In: Skin Cancer: New Research (Horizons in Cancer Research, Volume 31), Hauppauge NY, Nova Science Publishers, 2007.

Books (edited and written)

1. Thomas CR, Fuller CD. Biliary Tract and Gallbladder Cancer: Diagnosis and Therapy, Demos Medical Publishing, 2008.

Letters to the Editor

1. Garden AS, Fuller CD. Letter to the Editor regarding transoral laser microsurgery followed by radiotherapy in advanced oropharyngeal cancer. Head Neck 36: 1674-5, 2014.